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Melioidosis is a disease caused by the Gram-negative bacterium Burkholderia 
pseudomallei. This disease is endemic in South-east Asia and northern Australia and 
has been recognized as an emerging infectious disease worldwide. Research in recent 
years has demonstrated that the bacterium deploys many virulence factors and causes 
a disease with protean clinical presentations. The ability of the bacterium to survive 
intracellularly within phagocytes and non-phagocytes is postulated to help this 
pathogen persist in the body during latent or chronic conditions. We have focused on 
the interaction between bacteria and phagocytes, mainly monocytes and macrophages. 
We found that a virulent strain of B. pseudomallei induces a rapid oncotic death in 
monocytes, macrophages and dendritic cells through a caspase-1 dependent pathway. 
In the absence of caspase-1, infected cells die by apoptosis. Protein factors secreted by 
a type III secretion system encoded in the bsa locus of B. pseudomallei had been 
shown by other groups to mediate invasion of epithelial cells and phagosome escape in 
macrophages. We found that the bsa-encoded type III secretion system is also 
involved in the induction of caspase-1-dependent oncosis in macrophages. In addition, 
we have developed an efficient screening protocol based on the in vitro macrophage 
killing assay to identify transposon mutants with attenuated cytotoxicity. Upon 
characterization of transposon mutants, we discovered several bacterial genes 
potentially involved in the killing of macrophages. We believe that this novel 
description of macrophage death induced by B. pseudomallei and identification of new 




List of Tables 
No. Title Page
2.1 All the primers used and their annealing temperature  27 
2.2 All the plasmids used and constructed  27 
Escherichia coli and B. pseudomallei strains used  2.3 28 
Nucleotide changes in bsaQ in strain KHW with reference to bsaQ 
in strain K96243.  
2.4 34 
2.5 Putative bsa TTSS dependent effectors 43 
3.1 Caspase activities in infected cells. 67 
4.1 Summary of transposon mutants.  109 
4.2 Comparison of B. pseudomallei flagellar proteins to that of S. 
typhimurium LT2.  
111 
4.3 Homology of bsa proteins to that of SPI-I of S. typhimurium LT2. 112 
 
List of Figures 
 
No. Title Page
2.1.1 Alignment of BsaQ and InvA protein sequence 33 
2.1.2 Construction of plasmids for conjugation 35 
Confirmation of the genotype of bsaQ mutants 2.2.1 37 
Southern blot of bsaQ mutant genome 2.3.1 39 
2.4.1 Expression and secretion of BopE and BipD by B. pseudomallei 
KHW and bsaQ and bsaU mutants 
41 
B. pseudomallei induces rapid cell death in phagocytic cell lines 3.1.1 54 
3.2.1 Bacterial invasion is required for cytotoxicity 56 
B. pseudomallei KHW kills primary phagocytes 3.3.1 58 
3.4.1 Only virulent Burkholderia pseudomallei strains are able to induce 
cell death in THP-1 cells 
61 
B. pseudomallei killed phagocytes by induction of oncosis 3.5.1 64 
3.5.2 Nuclei were released rapidly during lysis of infected cells 65 
3.5.3 Bacteria infected THP-1 cells had little DNA fragmentation 66 
 10
3.6.1 Cell lysis is possibly caused by water-permeable pores formed on 
cytoplasmic membrane of infected phagocytes 
69 
3.7.1 An intact bsa TTSS was needed for full virulence 71 
3.7.2 BipB protein has high homology to SipB/IpaB 72 
3.8.1 Inflammatory cytokines are release during bacterial induced cell 
lysis 
74 
B. pseudomallei induced macrophage oncosis is caspase-1 
dependent 
3.9.1 77 
TUNEL staining of B. pseudomallei infected macrophages 3.10.1 80 
bsaQ mutant was not able to kill caspase-1 KO macrophages 3.10.2 82 
3.10.3 Caspase-3 activation in B. pseudomallei infected caspase-1 KO 
macrophages 
82 
3.11.1 Caspase-1 activation pathway by bacteria or bacterial products 88 
pOT182, transposon carrier plasmid. pOT182 plasmid contains Tn5-
OT182 transposon, a modified Tn5 
4.1.1 97 
4.1.2 Optimization of tetracycline concentration for selection of 
transposon positive mutants on agar 
98 
4.2.1 Visual screening of mutants with most severe attenuation of 
cytotoxicity to THP-1 cells 
102 
4.2.2 First round confirmation LDH assay 103 
4.2.3 Second round confirmation LDH assay 105 
4.2.4 Screening efficiency chart 106 
4.3.1 Characterization of transposon mutants 108 
4.3.2 Transposon insertion loci 114 
4.3.3 Bacteria motility assay 115 
4.4.1 Centrifugation restored the cytotoxicity of motility mutants 118 
Expression of flagellin in B. pseudomallei motility mutants 4.4.2 119 
 
List of Abbreviations 
AFC 7-amino-4-trifluoromethy coumarin 
AMC 7-amino-4-methoxy coumarin 
Ap ampicillin 
 11
ATCC American Type Culture Collection 
ATP adenosine triphosphate 
B. pseudomallei  base pair 
C1IMD caspase-1-independent macrophage cell death 
CATERPILLER  CARD, transcription enhancer, R(purine) binding, pyrin, lots 
of LRRs 
CFU colony forming unit 
Cm chloramphenicol 
chloromethyl ketone CMK 
DMSO dimethyl sulfoxide  
DNA deoxy-ribose nucleic acid 
ELISA enzyme-linked immunosorbent assay 
FCS fetal calf serum  
G-CSF granulocyte colony-stimulating factor 
GAP GTPase activating protein 
GEF guanine exchange factor 
GI gene identification (number in Genbank) 
Gm gentamicin 
GM-CSF macrophage and granulocytes-colony stimulating factor  
Hr hydrodynamic radius  
ICE interleukine-1β converting enzyme  
IFN interferon 
IHA indirect hemagglutination assay  
IKKβ Iκb kinase β 
IL interleukin 
Kb kilo-base pairs 
Km kanamycin 
KO knockout 
LB Luria-Bertani broth 
LDH lactate dehydrogenase  
LPS lipopolysaccharide 
M-CSF macrophage-colony stimulating factor  
MAPK mitogen activated protein kinase 
 12
Mb million base pairs 
MDD monocyte-derived dendritic cell 
MDM monocyte-derived macrophage 
MOI multiplicity of infection 
MTT methyl tetrazolium 
NALP NACHT-, LRR-, and PYD-containing protein 
nuclear Factor-kappa B NF-κB  
ORF open reading frame 
OD optical density 
PAMP pathogen associated molecular pattern 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PEG polyethylene glycol 
PI propidium iodide 
PTP protein-tyrosine phosphatase 
R (superscript) resistant/resistance 
S (superscript) sensitive/susceptible  
SDS-PAGE  sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
Sm streptomycin 
Salmonella pathogenicity island SPI 
STS staurosporine  
Tc tetracycline 
TEM transmission electron microscopy 
TLR toll-like receptors 
TNF tissue necrosis factor  
Tp trimethoprim 
TSA tryptic soy agar 
TTSS type III secretion system 





Chapter 1        Burkholderia pseudomallei and Melioidosis 
 
1.1 Burkholderia  pseudomallei and melioidosis 
A glanders-like disease, was first reported by Whitmore and Krishnaswami in the 
postmortem examinations of Rangoon vagrants in 1912 (Whitmore and Krishnaswami, 
1912). The disease is characterized by the presence of multiple abscesses in the liver, 
spleen, kidneys and subcutaneous tissues. In 1921, the name “melioidosis” (Greek: mé
lis a distemper of asses+ eidos resemblance + -osis condition) was proposed by 
Stanton and Fletcher for this new disease (Stanton and Fletcher, 1921). The causative 
agent of this disease is Burkholderia  pseudomallei, which is a Gram-negative bacillus. 
In the past, this bacterium had been named Bacillus pseudomallei, Bacillus whitmorii, 
Malleomyces pseudomallei and Pseudomonas pseudomallei. The current name was 
proposed by Yabuuchi et al. in 1992 (Yabuuchi et al. 1992).  
 
B. pseudomallei is a saprophytic, motile, facultative anaerobic and non-spore-forming 
soil bacterium. It is readily recovered from the soil and surface water in endemic 
areas. It can be cultured on many common laboratory media. This bacterium forms a 
characteristic wrinkled morphology on Ashdown’s selective agar, which contains 
crystal violet, glycerol, and gentamycin (Ashdown, 1979). Biochemical methods are 
available to identify this bacterium from other clinical specimens with high accuracy 
(Dance et al., 1989). This bacterium has a huge genome, represented by two 
chromosomes, one 4.07Mb and the other 3.17Mb. The genome of this bacterium has 
been completely sequenced recently (Holden et al., 2004) and the fully annotated 
version is available in Genbank (GI:53717639; GI:53721039).  
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B. pseudomallei can cause diseases in many animals, including birds, dolphins, pandas, 
non-human primates and humans (reviewed by Sprague and Neubauer, 2004). The 
clinical outcomes of the B. pseudomallei infection in human are extremely variable, 
ranging from acute septicaemia involving multiple organs, to a chronic localized 
infection, to subclinical infection (reviewed by White, 2003). Although the bacterium 
is capable of invading and forming abscesses in virtually any organ, the most 
commonly involved organ is the lung (reviewed by Cheng and Currie, 2005). Other 
commonly affected organs include liver, spleen, skeletal muscle and prostate. 
Involvement of multi-organ and septicemia are associated with high treatment failure 
and high mortality rate (reviewed by Leelarasamee, 2004). Because B. pseudomallei 
can survive intracellularly in mammalian cells in vitro, it is believed that the bacterium 
may persist in the host for many years. When the host develops more risk factors of 
melioidosis, an asymptomatic infection might progress to more severe forms of the 
disease. Exposure to the bacterium 62 years ago from an endemic area was believed to 
be the cause of the recent infection in a war veteran (Ngauy et al., 2005). However, 
such reactivation cases are rare and accounted for only 3 % of cases (Currie et al., 
2000a).  
 
There are three major suggested modes of bacterial acquisition, namely inhalation, 
ingestion and inoculation of contaminated water or soil particles. Inoculation through 
skin lesions is believed to be the major mode of acquisition (reviewed by Cheng and 
Currie, 2005). However, inhalation of contaminated aerosols during monsoon seasons 
or other extreme weather conditions like typhoon or tsunami was suggested to be the 
mode of acquisition in several reports (Currie and Jacups, 2003; Athan et al., 2005). In 
an animal model of B. pseudomallei infection, mice are more susceptible to intranasal 
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than intraperitoneal infection (Liu et al., 2002). Other modes of acquisition including 
person to person transmission of this bacterium are very uncommon (reviewed by 
Cheng and Currie, 2005).  
 
1.2 Endemic areas 
Melioidosis is endemic in Southeast Asia, especially in northeast Thailand, and 
northern Australia. In northeast Thailand, B. pseudomallei accounted for more than 20 
% of all community acquired septicemias (Chaowagul et al., 1989). In this area, the 
rate of seropositivity for B. pseudomallei and B. thailandensis in various populations 
may be up to 30-47 % (Khupulsup and Petchclai, 1986). The annual incidence of 4.4 
cases per 100,000 was reported in Ubon Ratchathani province in northeast Thailand 
over a 5-year period from 1987 to 1991 (Suputtamongkol et al., 1994). The annual 
incidence rate in the Top End of the Northern Australia was defined as 16.5 per 
100,000 between 1989 and 1999 (Currie et al., 2000b). In some years and certain 
restricted areas, the annual incidence rate as high as 40 cases per 100,000 was 
documented (Currie et al., 2004; Faa and Holt, 2002). The disease is also considered 
endemic in some other parts of Southeast Asia including Singapore, Malaysia, 
Myanmar and Vietnam. Research on melioidosis in China was summarized in recent 
reviews (Yang, 2000; Li and He, 1992). Sporadic cases had also been reported in areas 
outside endemic regions in recent years (reviewed by Dance, 2000; Dance, 1991; 
Cheng and Currie, 2005). With increasing global awareness of the disease, improved 
diagnostic facilities and increased traveling to Southeast Asia, it will not be surprising 
to see more cases of melioidosis reported in areas outside the endemic zone in the 
future.   
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 The first case of melioidosis in Singapore was recorded by Finlayson in 1920 
(Stanton and Fletcher, 1932). During the period of 1989 to 2004, there were 937 cases 
of melioidosis reported in Singapore, 58.5 cases per year (MOH statistics 2004a). 
Heavy rainfall often proceeds a surge of melioidosis in Australia (Currie and Jacups, 
2003). The correlation between heavy rainfall and melioidosis cases was considered 
less obvious in Singapore (Heng et al., 1998), probably because the general population 
is less exposed to muddy water due to the high degree of urbanization here. However, 
in March 2004, following the exceptionally high amount of monthly rainfall, there 
were 23 cases within one month with high percentage of patients presenting with 
pneumonic form of melioidosis (MOH Statistics 2004b).  
 
1.3 Diabetes mellitus and melioidosis  
Clinical risk factors for melioidosis have been reviewed in detail recently (Cheng and 
Currie, 2005). The occurrence and severity of this disease are strongly associated with 
underlying chronic diseases. Type II diabetes mellitus is one of the most common 
underlying conditions in melioidosis patients (Currie et al., 2004; Merianos et al., 
1993; Suputtamongkol et al., 1999; Malczewski et al., 2005; Chen et al., 2005; 
Pagalavan 2005; Heng et al., 1998). Studies in Canada determined the relative risk 
ratio for diabetic over non-diabetic population to all infectious diseases ranging from 
0.89 to 4.39 (Shah and Hux, 2003). In comparison, the reported risk ratio for diabetics 
to melioidosis was 5.9 to 13.1 in Thailand and Australia (reviewed by Cheng and 
Currie, 2005). However, there are no satisfactory mechanistic explanations on why 
people with diabetes are more susceptible to B. pseudomallei infection. In 1993, one 
study demonstrated that insulin was able to inhibit B. pseudomallei growth in vitro 
(Woods et al., 1993). However, it was found later that the inhibitory effect of the 
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commercial insulin preparation might be due to the presence of preservatives 
(Simpson and Wuthiekanun 2000). Furthermore, diabetic melioidosis patients in 
Thailand (Simpson et al., 2003) and Australia (Currie, 1995) are mostly having Type 
II diabetes, which is insulin-independent. Thus insulin may not play an important role 
in determining the susceptibility to melioidosis. In 2003 Simpson et al. (2003) 
proposed that the susceptibility might be due to the impairment of neutrophil function 
(Geerlings and Hoepelman, 1999) observed in patients with diabetes and renal 
impairment, which is also a risk factor for melioidosis. This theory was supported by a 
clinical report suggesting the beneficial effect for adjunctive granulocyte colony-
stimulating factor (G-CSF) for treatment of septic shock due to melioidosis (Cheng et 
al., 2004). However, experiments in vivo did not find any therapeutic effect for G-CSF 
on treatment of murine melioidosis (Powell et al., 2003). Alternatively, exaggerated 
inflammatory responses in diabetic animals towards microbial products might have 
worsened the outcome of B. pseudomallei infection (Gan, 2005). Therefore, there is an 
urgent need to develop a melioidosis model using Type II diabetic animals to evaluate 
these issues directly. 
 
1.4 Diagnosis 
The diagnosis of melioidosis is intrinsically difficult as clinical presentations vary 
from patient to patient. Recovering B. pseudomallei by culture from clinical samples 
remain the most conclusive method for diagnosis of melioidosis. However, culture 
based methods are time consuming. It may take days to show the characteristic colony 
morphology on selective media. The indirect hemagglutination assay (IHA) based 
serological test is relative rapid and easy to perform. It was developed over 30 years 
ago (Alexander et al., 1970) but it remains the most widely used test despite its poor 
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sensitivity and specificity (reviewed by Cheng and Currie, 2005). Several new assays 
have been developed in recent years based on ELISA or PCR. One microarray based 
assay was developed recently to detect B. pseudomallei and B. mallei polysaccharide, 
which is a more defined bacterial antigen (Parthasarathy et al., 2006). This method of 
detection promises to be a more specific test for these two bacteria.  
 
1.5 Treatment 
B. pseudomallei exhibits an intrinsic resistance to many groups of antibiotics, 
including many third-generation cephalosporins, penicillins, rifamycins, 
aminoglycosides, quinolones and macrolides (Thibault et al., 2004). Conventionally, a 
combination of four antibiotics; chloramphenicol + doxycycline + trimethoprim + 
sulfamethoxazole, was used to treat acute melioidosis patients with mortality rate as 
high as 80 %. In 1989, an open randomized clinical trial in Thailand demonstrated that 
ceftazidime, a third-generation cephalosporin, halved the mortality rate of severe 
melioidosis (White et al., 1989). Since then, ceftazidime became the drug of choice for 
treatment of severe melioidosis. The drug is administered (alone or with other drugs) 
intravenously at 120-200 mg/kg/day for 10 to 14 days. The parental antibiotic 
treatment must be followed with an oral intake of the conventional four-drug 
combination for three to six months to reduce the rate of relapse (Rajchanuvong et al., 
1995). Despite this long-term intensive antibiotic treatment, the rate of relapse is high 
especially in patients with severe disease (Chaowagul et al., 1993).  
 
A new glycylcycline antibiotic, tigecycline, was tested in vitro against B. pseudomallei 
and B. thailandensis recently (Thamlikitkul and Trakulsomboon  2006). It was 
suggested that tigecycline might be effective against intracellular bacteria such as B. 
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pseudomallei. Thus, it might to able to reduce the relapse rate of B. pseudomallei 
infection, though it remains a speculation until clinical trials can be conducted.  
 
1.6 Putative virulence mechanisms  
Many putative virulence determinants have been identified in B. pseudomallei 
(Wiersinga et al., 2006). B. pseudomallei is serum resistant. It can survive and 
multiply in human and other animal serum (DeShazer et al., 1998). It produces a 
polysaccharide capsule and the capsule is able to reduce complement deposition on the 
bacterial surface (Reckseidler et al., 2005). Thus, the capsule protects the bacterium 
from complement mediated cell lysis and opsonization. A capsular mutant of B. 
pseudomallei is severely attenuated in virulence in the hamster model of B. 
pseudomallei infection (Reckseidler et al., 2001). Bacterial flagella are important for 
motility and adherence. A fliC mutant of B. pseudomallei was found to be completely 
avirulent in BALB/c mice (Chua et al., 2003). Type III secretion systems (TTSS) are 
identified in many Gram-negative bacterial pathogens and frequently is the key 
virulence determinant in these pathogens (reviewed by Hueck, 1998). In B. 
pseudomallei, three such systems are found. The bsa TTSS was shown to be important 
for infection in animals. It confers the ability to invade and survive in mammalian 
cells (Stevens et al., 2002). Strains deficient in bsa TTSS are avirulent in both mouse 
and hamster models (Stevens et al., 2004; Warawa and Woods, 2005). The TTSS is 
likely to be one of the effector systems regulated by quorum sensing, which is also an 
important virulence mechanism in B. pseudomallei (Ulrich et al., 2004). The in vivo 
relevance of many other putative virulence factors is less well defined.  
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Several animal models of B. pseudomallei infection were developed to study 
pathogenesis of melioidosis. The mouse model is most well characterized. BALB/c 
mice are relatively susceptible to B. pseudomallei infection, while C57BL/6 mice are 
about 100 times more resistant (Leakey et al., 1998; Hoppe et al., 1999; Liu et al., 
2002). The host factors contributing to the differential susceptibility are yet to be 
defined.  Syrian hamsters are extremely sensitive to B. pseudomallei infection. Less 
than 10 CFU of bacteria is required to kill 50 % of hamsters in two days (Reckseidler 
et al., 2001). Diabetic (Type I) infant rat model was developed based on the 
observation that insulin inhibited B. pseudomallei growth in vitro (Woods et al., 1993). 
As discussed above, diabetic melioidosis patients are mostly having Type II diabetes. 
Thus, interpretation of results obtained using this model should be treated with caution.   
 
1.7 Vaccine development  
Melioidosis is difficult to diagnose and treat. The rate of relapse after recovery from 
first infection is high especially with the acute form of disease. The long-term 
antibiotic treatment is expensive. The best way to protect those people at risk is 
through vaccination. Efforts have been made to develop a vaccine for melioidosis, but 
it is not yet available. Immunization of animals with avirulent strains or auxotrophic 
mutants offers partial protection from subsequent lethal challenge (Stevens et al., 2004; 
Atkins et al., 2002). However, live attenuated vaccines are unlikely to be approved for 
human use but could potentially be useful for animals such as dolphins or gorillas in 
oceanariums and zoos. Subunit vaccines could potentially be more promising. The 
capsule of B. pseudomallei can inhibit the alternative activation of complement 
cascade by reducing surface deposition of C3b (Reckseidler et al., 2005). In principle, 
antibodies against surface antigens might re-sensitize the bacterium to complement via 
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classical activation pathway. In fact, Nelson et al. showed that lipopolysaccharide or 
capsular polysaccharide immunization protected against intraperitoneal challenge of B. 
pseudomallei but not aerosol route (Nelson et al., 2004). Flagellin is also a potential 
vaccine target. Recent studies demonstrated that mice immunized with DNA plasmid 
encoding flagellin protected five out of six animals for up to seven days (Chen et al., 
2006a). Other strategies including immunization with dendritic cells pulsed with heat 
killed bacteria (Elvin et al., 2006) have shown promising results demonstrating the 
importance of eliciting a cell-mediated immune response. Warawa and Woods 
predicted in a review paper that a human melioidosis vaccine could be in pipeline by 
2007 (Warawa and Woods 2002). However, there is no report suggesting any 
candidate vaccines ready for clinical trials yet.  
 
1.8 Aims and rationale of this project 
Macrophages play an important role in host immunity against microbes. Studies on the 
interaction between bacterial pathogen and host macrophages have revealed valuable 
insights of pathogenesis of bacteria (Navarre and Zychlinsky, 2000). It has been 
previously observed that virulent B. pseudomallei kills macrophage cells in vitro (Gan 
Y. H. and Liu B. P., unpublished observation). We propose to investigate the 
mechanism of macrophage cell death induced by B. pseudomallei. It has been shown 
that bsa TTSS of B. pseudomallei plays an important role in virulence of the bacterium 
(Stevens et al., 2004; Warawa and Woods, 2005).  The potential role of bsa TTSS in 
macrophage cell death is being investigated. To facilitate the study on bsa TTSS, I 
generated a bsa TTSS mutant from a clinical strain isolated from a local patient. The 
mutant strain will be useful for future work as well in addition to studies proposed for 
this project. Furthermore, I developed a screening assay based on macrophage killing 
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to identify bacterial products that are important in induction of macrophage cell death. 
These bacterial products are potential virulence factors and their roles in pathogenesis 
























Chapter 2        Generation of a Type III secretion system 




Secretion of protein factors across the cell membrane into the extracellular 
environment is very important to all Gram-negative bacteria. Protein secretion is 
required for numerous aspects of the bacterial life cycle, including organelle 
biogenesis, nutrient acquisition, and virulence-factor expression. Bacteria have 
evolved a variety of mechanisms for this purpose. These secretion systems are subject 
of intensive research focus in recent years, as many of them are responsible for 
secretion of several clinically important bacterial toxins. Of particular interest is the 
type III secretion system (TTSS) (reviewed by Hueck, 1998; Galan and Collmer, 
1999), discovered in an increasing number of pathogenic bacteria including pathogens 
of both plant and animal kingdoms (Puhler et al., 2004). The function of TTSS is often 
essential for bacterial virulence.  
 
TTSS is capable of delivering virulence factors directly across the host cytoplasmic 
membrane into the cytoplasm of host cells. The delivery, or more accurately, injection, 
is achieved through a bacterial surface organelle termed injectisome, which is 
essentially a nano-syringe. The injectisome consists of three parts, the needle, the base 
and the export apparatus associated with the inner membrane of the base (reviewed by 
Galan, 2001). Genes encoding components of the injectisome, approximately 20 of 
them, are highly conserved among different TTSSs of distantly related bacteria. These 
genes are frequently present within a pathogenicity island and their G + C content 
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usually significantly deviated from the rest of the genome. It is suggestive of 
horizontal gene transfer among pathogenic bacteria. The homology of these genes 
with those of flagellar export system also gives an indication of the evolutionary origin 
of the virulence related TTSS. However, detailed phylogenic analysis indicated that 
the TTSS and flagellar export systems shared a common ancestor, but they have 
evolved independently from each other hundreds of millions of years ago (Gophna et 
al., 2003).  
 
In contrast to conserved structural features, effector proteins secreted through TTSS 
are much more diverse. Once in the host cell, these effectors are able to interfere with 
many host signaling pathways. In many instances, bacteria employ TTSS effectors to 
modify host immune responses mounted against them (reviewed by Espinosa and 
Alfano, 2004). For example, Yersinia spp. secreted YopH has protein-tyrosine 
phosphatase (PTP) activity and is able to suppress the activation of the PI3K/Akt 
pathway, which leads to production of proinflammatory cytokines (Guan and Dixon, 
1990).  Another Yop protein, YopJ/H, is a cysteine protease which inhibits Iκb kinase 
β (IKKβ) activation (Orth et al., 2000; Carter et al., 2003). IKKβ is essential for NF-
κB activation and cytokine production. SptP of Salmonella is a multifunctional 
effector with GTPase activating domain in its N-terminal and a PTP domain in its C-
terminal (Kaniga et al., 1996). It can inhibit the MAPK pathway (Hobbie et al., 1997) 
and downregulate proinflammatory cytokine interleukin (IL)-8 production (Haraga 
and Miller, 2003). Several effectors, including YopJ/P, IpaB (Shigella)/SipB 
(Salmonella), are capable of inducing macrophage cell death (Miller et al. 1997; Chen 
et al., 1996; Hersh et al., 1999). 
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Some animal pathogens like Salmonella have two TTSSs, functioning at different 
stages of the infection in the host (reviewed by Guiney, 2005). Interestingly, there are 
three TTSS found in the completely sequenced B. pseudomallei genome (Winstanley 
et al., 1999; Rainbow et al., 2002; Holden et al.,  2004). Two of them (TTSS1&2) 
resemble that of Ralstonia, a plant pathogen (Attree and Attree, 2001). The third one, 
named Burkholderia secretion apparatus (bsa, TTSS3) resembles inv/mxi TTSS in 
Salmonella and Shigella (Attree and Attree, 200; Stevens et al., 2002). Within the bsa 
TTSS locus, there are several putative effector genes encoding proteins with high 
homology to Salmonella and Shigella TTSS effectors. bsa TTSS is the only one that is 
highly conserved in all B. pseudomallei and related B. mallei and B. thailandensis 
strains (Kim et al., 2005). The role of TTSS3 in survival and persistence within 
murine macrophage-like cell line was demonstrated (Stevens et al., 2002). The 
importance of TTSS3, but not TTSS1/2, was further demonstrated in a hamster model 
of B. pseudomallei infection ((Warawa and Woods, 2005). In the work described in 
this chapter, we generated a TTSS3 deficient strain of B. pseudomallei bsaQ. With this 
mutant strain, we will be able to uncover more function of this gene cluster in disease 
pathogenesis.  
 
2.2 MATERIALS AND METHODS 
 
2.2.1 PCR primers, plasmids and bacteria strains 
Polymerase chain reaction (PCR) primers were designed with the help of Vector NTI 
software (version 7.1, Informax inc., Bethesda, MD, USA). All the primers used in 
this study are listed in Table 2.1. Cloning vector pGEMT-easy was purchased from 
Promega (Madison, WI, USA). Other plasmids used and generated in this study were 
listed in Table 2.2. Escherichia coli strains used during cloning and B. pseudomallei 
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strains and mutants were listed in Table 2.3. Bacterial cultures were grown under 
aerobic conditions at 37°C in Luria-Bertani (LB) broth (Becton Dickinson, 
Cockeysville, MD) or agar. The antibiotic concentrations used for resistant E. coli 
strains were as follows: ampicillin, 100 μg/mL; gentamicin, 20 μg/mL; kanamycin, 10 
μg/mL. The antibiotic concentrations used for B. pseudomallei were: kanamycin, 250 
μg/mL; streptomycin, 100 μg/mL. All antibiotics were purchased from Sigma (St 
Louis, MO, USA).  
 
Table 2.1 All the primers used and their annealing temperature.  
Primer Sequence (5’-3’) Annealing temperature 
(°C ) 
bsaQF3 ATGCTGAAGAATCTCCTGATCAAGG 52 
bsaQR3 CTCTCCTTAGATCGTCTTCAACAC 52 
bsaQR4 ATGCGCTGCACCGAAATG 51 
bsaQF4 TGAAAGCCAGCTGTACG 55 
KmF3 GTGGATGACCTTTTGAATGACC 51 
KmF4(=KmR4) AAAGGTCATCCACCGGATC 55 
T7 55 GTAATACGACTCACTATAGGGC 
SP6 50 GATTTAGGTGACACTATAG 
 
Table 2.2 All the plasmids used and constructed.  
Name Description Source or 
reference 
RpGEMT-easy Vector for PCR cloning; Ap Promega  
RpGEMT/bsaQ  Ap ; 2.1 kb bsaQ PCR product ligated into 
pGEMT-easy 
This study 
de Lorenzo et 
al., 1990 
pUT/Km Source of kanamycin resistance cassette 
(KmR); oriR6K, mobRP4, KmR R, Ap
Mobilizable allelic exchange vector; traJ, pJQ200mp18 Quandt and 
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sacB, GmR Hynes, 1993 
pJQ200/bsaQ  GmR; end filled NotI digested pGEMT/bsaQ 




KmR; GmR; end filled EcoRI  digested 
pGEMT/Km fragment containing Km
This study 
R ligated 
into NarI site of pJQ200/bsaQ; KmR  in #4 
&5 has different orientation 




Table 2.3 Escherichia coli and B. pseudomallei strains used  
Strain Description Source or 
reference 
E. coli    
endA1, recA1, gyrA96, thi, hsdR17 (rk–, 
mk+), relA1, supE44, ∆( lac-proAB), [F′, 
traD36, proAB, laqIqZ∆M15]; cloning 
host 




   
Gibco-BRL, DH5αλpir  λpir lysogen of DH5α for replication of 






   





BmBB B), recA13, ara-14, 
proA2, lacY1, galK2, rpsL20, xyl-5, mtl-1 
   
Liu et al., 
2002 
B. pseudomallei  Wild-type parental strain, clinical isolate, 
KmS SKHW 
 
   KHWbsaQ::Km#4-6 
, Tp , GmR, SmR 
  
KHWbsaQ::Km, KmR This study 
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KHWbsaQ::Km#4-7   
KHWbsaQ::Km#4-105   
KHWbsaQ::Km#5-14   
KHWbsaQ::Km#5-41   
KHWbsaQ::Km#5-69   
   
KHWbsaU::Tn5OT182 KHWbsaU::Tn5-OT182 This study 
 
2.2.2 Cloning and subcloning  
Molecular biology techniques were performed as described (Sambrook and Rusell, 
2001). bsaQ gene was amplified using primer pair bsaQF3/bsaQR3 from genomic 
DNA of KHW by BIOTAQ DNA polymerase (Bioline, Springfield, NJ, USA) 
following the manufacturer’s instruction. PCR reaction mixture contained 0.25 μg of 
template DNA, 1x NH Cl buffer, 0.8 μM of each primer, 1.4 mM MgCl4 2, 400 μM of 
dNTP, 4 % DMSO and 1 unit of polymerase. Cycling parameters were, 95°C for 4 
minutes, followed by 30 cycles at 95°C for 1 minute, 52°C for 1 minute, and 72°C for 
2 minutes and a final extension at 72°C  for 10 minutes. The PCR product was 
separated by 1 % agarose gel and band of correct size was excised from the gel and 
purified using Qiagen gel extraction kit (Hilden, Germany).  The 200 ng of purified 
product was ligated into pGEMT-easy vector using T4 ligase (Promega, Madison, 
WI.). Ligation product was transformed into E. coli JM109 competent cells via heat-
shock. Transformants were selected with 100 μg/mL ampicillin. Plasmids were 
prepared from positive clones using Wizard miniprep kit (Promega). The insert in the 
plasmid was sequenced to completion using primers T7, SP6, bsaQF4, bsaQR4. DNA 
sequencing was performed with dideoxy chain termination method using ABI Big Dye 
terminator kit (Applied Biosystems, Foster City, USA) and analyzed using an 
Automatic Sequencer ABI 377 (Applied Biosystems). 
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 bsaQ fragment in pGEMT/bsaQ was excised using NotI (Promega) and the end was 
completely filled in with Klenow fragment of DNA polymerase (Promega). bsaQ was 
then blunt-end ligated into SmaI (Promega) site of pJQ200mp18. The blunt ends of 
SmaI-digested pJQ200mp18 were dephosphorylated with shrimp alkaline phosphatase 
(Roche Diagnostics GmbH, Mannheim, Germany) to reduce the rate of self ligation. 
The kanamycin resistance cassette (KmR  ) was prepared from end filled EcoRI  
(Promega) digested pUTKm. KmR was then ligated into the NarI (Promega) site on 
the bsaQ of pJQ200/bsaQ. Two independent pJQ200/bsaQ::Km constructs were 
obtained, namely #4 & # 5. Both were sequenced with primer bsaQF4 and bsaQR4 to 
confirm the sequence.  
 
2.2.3 Tri-parental conjugation  
pJQ200/bsaQ::Km#4 or #5 were delivered to B. pseudomallei strain KHW by 
triparental mating as described by de Lorenzo and Timmis (1994). Briefly, donor 
DH5αλpir (pJQ200/bsaQ::Km), recipient strain KHW and the helper strain 
HB101/pRK600 were grown at 37oC overnight in 5 mL LB with appropriate 
antibiotics. The cells were subcultured (1:100) the next day in 3 mL of LB. When the 
OD600 was about 0.9, the cells were harvested, washed and resuspended in 200 μl LB. 
Donor and helper cells (100 μl each) were mixed and incubated for 30 min at room 
temperature. Recipient cells (200 μl) were added and the mixture was spot-inoculated 
onto the surface of pre-warmed LB agar plates. After incubation overnight at 37oC, the 
cells were scraped off and were resuspended in 1 ml 0.9 % NaCl. Serial dilutions were 
plated on LB agar containing 250 μg/mL kanamycin and 100 μg/mL streptomycin to 
counter select against donor, helper and untransformed recipient cells. The second 
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round of selection is 200 μg/mL kanamycin and 5 % sucrose, which selects against 
those KHW colonies harbouring the pJQ200 plasmid containing sacB. Generation and 
characterization of bsaU::Tn5-OT182 will be described in Chapter 4.  
 
2.2.4 Southern blot 
Genomic DNA was prepared from B. pseudomallei strain KHW and bsaQ mutants 
using UltraClean Microbial DNA isolation kit (Mobio laboratories, Carlsbad, CA, 
USA). 2 μg of DNA was digested with NotI overnight at 37°C before being separated 
on 0.8 % agarose gel. DNA was then blotted onto nylon membrane (BioRad, 
Richmond, CA, USA) and fixed by heating at 120°C for half an hour. The blot was 
probed with a 2 kb fragment amplified from KmR with KmF4 and KmR4 primers. The 
blot was reprobed with the full length bsaQ fragment amplified with bsaQF3 and 
bsaQR3. The probe was labeled and detected with DIG high prime DNA labeling and 
detection starter kit (Roche).  
 
2.2.5 Western blot 
10 mL log phase culture of wild type, bsa TTSS mutants bsaQ or OT9H7(bsaU::Tn5-
OT182) was centrifuged at 3000 g for 5 minutes. Bacterial pellet was lysed with 
bacterial lysis buffer (8 M Urea, 0.1 M NaH PO2 4, 0.01 M Tris-Cl, pH 8). Supernatant 
was filtered through 0.2 μm syringe filter to completely remove bacteria. Proteins in 
the supernatant were precipitated with trichloroacetic acid (25 % of supernatant 
volume). 20 μg of protein from bacterial cell lysate or precipitate of culture 
supernatant was separated by 10 % SDS-PAGE and transferred to nitrocellulose 
membrane. The membrane was then probed with rabbit polyclonal antiserum to BopE 
or BipD (1:100, kind gift from Dr. Mark P. Stevens, Institute for Animal Health, UK) 
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and detected with horseradish peroxidase-conjugated mouse anti-rabbit IgG (1:5000, 
Sigma).  Densitometry analysis of protein bands on the film was performed with 
Image J as instructed by software producer. Band intensity was presented as a relative 




2.3.1 Generation of bsaQ insertion mutant 
The structural proteins of TTSS apparatus are highly conserved. The largest structural 
protein in TTSS3 of Burkholderia pseudomallei is encoded by the bsaQ gene. It is a 
homolog of InvA (72 %), an inner membrane protein of TTSS encoded by Salmonella 
pathogenicity island (SPI)-I locus (Figure 2.1.1). It was shown that invA mutant has no 
functional TTSS (Kubori et al., 2000). Thus it is highly possible that bsaQ mutant will 
have a TTSS3-null phenotype. Figure 2.1.2 is a flow chart showing the cloning 




Figure 2.1.1 Alignment of BsaQ (BPSS1543, GI:52212978) and InvA (GI:16766202.) 
protein sequence. Overall, there is 55 % identity and 72 % similarity between these 
two proteins. Identical residues were shadowed with black background. Similar 









Based on the available genomic sequence information (B. pseudomallei K96243 
chromosome 2 GI:53721039), a pair of primers (bsaQF3/R3) was designed for PCR to 
clone the full length bsaQ gene from genomic DNA of B. pseudomallei strain KHW. 
The PCR product was first cloned into pGEMT-easy vector. Plasmid recovered from 
the positive clone was fully sequenced. We found that the cloned bsaQ gene align well 
with database sequence except for 5 silent base substitutions (Table 2.4).  
 
Table 2.4 Nucleotide changes in bsaQ in strain KHW with reference to bsaQ in strain 
K96243.  
Position from start codon  Nucleotide changes Codon affected  
162 C to T GG(C/T) Gly 
633 T to C GG(T/C) Gly 
906 C to T TT(C/T) Phe 
1095 G to A CC(G/A) Pro 
1518 G to A GA(G/A) Glu 
  
bsaQ fragment (NotI digest) was then subcloned into the SmaI site of suicide vector 
pJQ200mp18. Kanamycin resistant gene cassette (EcoRI digest of pGEMT/KM) was 
then ligated into NarI site of bsaQ. Clones 4 and 5 of the construct were found to have 
KmR inserted in different orientation. They were used to generate independent mutant 
clones. All the plasmids generated in this study were sequenced. 
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 Figure 2.1.2 Construction of plasmids for conjugation. PCR fragment of bsaQ was 
first cloned into pGEMT-easy vector, then it was subcloned into SmaI site of 
pJQ200mp18. EcoRI digested KmR fragment was inserted into the NarI site of the 
bsaQ gene. The plasmid pJQ/bsaQ::KmR was used to generate bsaQ mutants by 
homologous recombination. All the incompatible restriction ends were completely 








Plasmid pJQ/bsaQ::KmR was transformed into E. coli DH5αλpir. The construct was 
then introduced into B. pseudomallei strain KHW via triparental conjugation with the 
help of E. coli HB101/pRK600. Reciprocal recombinants were first selected by plating 
the conjugation mixture on TSA with 100 μg/mL of streptomycin and 200 μg/mL of 
kanamycin. Positive clones were plated on TSA with 5 % sucrose to cure the plasmid. 
Finally, six clones were obtained. These clones were then characterized and used for 
further studies.  
 
2.3.2 PCR of bsaQ mutant 
We have observed previously that B. pseudomallei has some degree of resistance to 
sucrose toxicity conferred by sacB gene in the pJQ200 plasmid. Frequently sacB 
containing plasmid was retained in the genome. We thus used PCR to confirm the 
genotype of all the mutants. Primers specific for bsaQ and KmR were paired up to 
detect bsaQ::KmR construct or the original gene. As shown in Figure 2.3.1 first row, 
bsaQ::KmR was present in all the 6 mutants, but intact bsaQ was retained in 2 clones. 
It was very likely that only single cross over occurred during recombination, and the 
entire plasmid was inserted into the genome. Nevertheless, bsaQ was lost in 4 other 





Figure 2.2.1 Confirmation of the genotype of bsaQ mutants. Genomic DNA isolated 
from mutants as well as wild type bacteria was amplified with primer pairs specific for 
mutant allele (A) or wild type allele (B). Primer binding sites were illustrated on the 
right. KmF3 primer can recognize either end of the KmR fragment. Lanes 1-6 were 
bsaQ mutants isolated. Lane 7 was KHW. The positive control lane (+) was 













2.3.3 Southern blot of bsaQ mutant genome for presence of kanamycin resistant 
gene 
To further prove that there was no non-specific insertion of the construct in the mutant 
genome, we performed Southern blot. Genomic DNA was first digested with NotI, 
then separated on 0.8 % agarose gel before transfer onto nylon membrane. The blot 
was first probed with KmR fragment. As shown in Figure 2.3.1 upper blot, 4 clones 
had the single band at the predicted position of 6 kb. This demonstrated that these 4 











 Figure 2.3.1 Southern blot of bsaQ mutant genome. Genomic DNA from 6 bsaQ 
mutants (lane 1-6) and KHW (lane 0) was digested with NotI. Molecular weight 
marker was in lane M. The blot was first probed with KmR fragment. The same blot 
was then probed with bsaQ fragment. Three possible genotypes were illustrated on the 













2.3.4 Secretion of BopE and BipD 
It has been shown previously that BopE protein encoded within the bsa locus is a bona 
fide TTSS effector (Stevens et al., 2003). BipD is one of the translocators, which is 
also secreted. We thus tested the ability of bsaQ mutant to secrete BopE and BipD into 
culture supernatant. We picked one of the 4 mutant clones with correct genotype, 
clone #5-14 (lane 4 in Figure 2.2.1 and 2.3.1), for all our subsequent experiments. We 
first confirmed that BopE and BipD were indeed expressed in bsaQ. As shown in 
figure 2.4.1 (Lysate), both were present in the cell lysate of bsaQ and KHW at similar 
amount. Proteins were precipitated from log phase culture supernatant. BopE and 
BipD can be readily detected in wild type bacterial culture supernatant, but only trace 
amount could be detected in bsaQ or bsaU culture supernatant (Figure 2.4.1 







Figure 2.4.1 Expression and secretion of BopE (A) and BipD (B) by B. pseudomallei 
KHW and bsaQ (#5-14) and bsaU mutants (bsaU::Tn5-OT182, described in chapter 
4). BopE and BipD were expressed intracelluarly in all the three bacterial strains. In 
contrast, they were only detectable in the supernatant of wild type bacterium but not in 













TTSS plays an essential role in bacterial pathogenesis. B. pseudomallei has three 
TTSSs. Two of them have high homology to TTSS of plant pathogen Ralstonia. These 
two TTSSs possibly play a role in interaction with plants. However, there are no 
known studies investigating the possible interaction between B. pseudomallei and 
plants despite the fact that B. pseudomallei, as a soil bacterium, should have ample 
chances to interact with plants. The third TTSS present in the B. pseudomallei genome 
has high homology to TTSS of Salmonella and Shigella. Both are notorious 
enteropathogenic bacteria, often associated with food poisoning. Both bacteria invade 
the host through the mucosal surface of the intestine. Their TTSS is essential for host 
invasion. B. pseudomallei is also capable of invading host respiratory mucosal surface. 
One would expect that bsa TTSS is required for this mucosal invasion. In fact, it has 
been shown that bsa TTSS-defective mutants have strongly attenuated virulence in 
mice inoculated intranasally with B. pseudomallei (Stevens et al., 2004).  
 
There were more than a dozen effectors secreted by SPI-1 TTSS of Salmonella (Galan, 
2001). Nine putative effectors of bsa TTSS have been identified so far in the B. 
pseudomallei genome through homology searches (Table 2.5). Mutant strains of most 
of these effectors have been generated recently. Virulence of bapA and bapC mutants 
was not attenuated in the hamster model (Warawa and Woods, 2005). Virulence of 
bopE mutant was not significantly attenuated in BALB/c mice, while bopA and bopB 
mutants were slightly attenuated in virulence (Stevens et al., 2004). However, the 
degree of attenuation in single effector mutants was much less than that of non-
secreting mutants (Stevens et al., 2004), suggesting that multiple effectors contribute 
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to virulence in vivo. Since only BopE protein was expressed and characterized in vitro 
so far (Stevens et al., 2003), it remains to be proven whether the rest of the putative 
effectors listed in Table 2.5 are bona fide bsa-dependent effectors.  
 
Table 2.5 Putative bsa TTSS dependent effectors 
Putative bsa TTSS 
effector* 
Homolog Predicted function Reference 
(GI) 




Stevens et al. 2004 BopB (BPSS1514a) SopB** Lipid phosphatase 
(GI:13469836)




Suparak et al., 2005 BipB (BPSS1532) SipB 53 % Translocator  
(GI:16766191) Bind and activate 
caspase-1 




BipD (BPSS1529) SipD 50 %  Translocator Stevens et al. 2004 
(GI:16766189)
Zahrl D et al., 2005; BapC(BPSS1526) IagB 60 %  Invasion protein  
(GI:16766183) Peptidoglycanase 
in vitro   
Warawa and Woods, 
2005 
 
BapB (BPSS1527) IacP 51 % Putative acyl 
carrier protein 
Warawa and Woods, 
2005 (GI:16421428) 
BapA (BPSS1528) No significant 
homolog 
Unknown  Warawa and Woods, 
2005 
*The code in parentheses refers to ORF number in the annotated genome. 
** No significant overall homology; only the conserved CX5R of lipid phosphatase 
motif was identified.  
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With the available B. pseudomallei genome, one can easily identify effectors with 
sequence homology to known virulence factors. However, it is a challenge to discover 
those effectors with no obvious homolog in the database, particularly those not 
encoded within the bsa locus. BopE is a homologue of SPI-I effector SopE, a guanine 
exchange factor (GEF) for Rho GTPases (Rudolph et al., 1999). It has been shown 
that BopE is required for invasion of epithelial cells, which is similar to SopE (Stevens 
et al., 2003). Salmonella SPI-I also secretes another effector SptP, C-terminal of 
which has activity of a GTPase activating protein (GAP), to switch off the Rho 
GTPase activated by SopE after bacterial entry (Fu and Glana, 1999). However, there 
is no known homolog of any GAP present in the B. pseudomallei genome. It is 
probably undesirable to have constitutively activated Rho GTPases after bacterial 
invasion. Thus it is very likely that there is an effector functionally mimicking GAP 
but with novel primary amino acid sequence. Furthermore, more virulent strains of B. 
pseudomallei might have unique effectors comparing to the less virulent strains. 
Without any sequence information, such potential effectors can only be identified 
through functional screening.  
 
We have generated a bsa TTSS-null strain from a virulent B. pseudomallei strain. 
With this mutant, we will be able to test the involvement of bsa TTSS in more 
functional assays, particularly using in vitro cell culture models, such as killing of 
macrophages and cytokine production by epithelial cells. Once we establish a role of 
bsa TTSS in these infection models, we will design screening assays to identify 
potential effectors involved. Through these studies, we hope to be able to isolate novel 
effectors and understand the pathogenesis of the bacterium better.  
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Chapter 3       Burkholderia pseudomallei induced 




Macrophages are one of the most important professional phagocytes in the body. They 
are capable of killing a wide spectrum of invading microbes with powerful lysosomal 
systems. In addition, macrophages are potent sources of inflammatory cytokines that 
orchestrate other immune responses. Furthermore, macrophages are able to present 
antigens derived from degraded pathogen in the lysosome to T cells directly. 
Therefore, macrophages are the front line defense against pathogens. On the other 
hand, many bacterial pathogens have evolved mechanisms to modulate macrophage 
cell function such as vesicular trafficking, antigen presentation, production of 
inflammatory cytokines, or anti-microbial responses (reviewed by Rosenberger and 
Finlay, 2003). In the extreme, many pathogens can even kill macrophages before 
being killed themselves (DeLeo, 2004). For example, Shigella and Salmonella are able 
to trigger caspase-1 dependent macrophages cell death within a few hours using 
effectors secreted through TTSS (Chen et al., 1996; Hersh et al., 1999).  
 
B. pseudomallei is able to invade many professional phagocytes, including rat alveolar 
macrophages, mouse macrophage-like cell lines J774 and Raw264 and human 
monocyte-like U937 cells (Jones et al., 1996; Harley et al., 1998). Several 
mechanisms of invasion have been documented. Shortly after being phagocytosed, B. 
pseudomallei can escape from the endocytic vesicles and thus avoid the attack of 
degradative lysosomal enzymes (Stevens et al., 2002). It was also shown that 
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intracellular B. pseudomallei could prevent nitric oxide production by inhibiting the 
expression of inducible nitric oxide synthase (iNOS) by mouse macrophages 
(Utaisincharoen et al., 2001). Induction of apoptosis in J774A.1 cells by the bacterium 
was reported based on the appearance of DNA laddering (Kespichayawattana et al., 
2000). However, DNA fragmentation is no longer considered a reliable apoptosis 
marker (Leist and Jaattela, 2001). In the studies presented in this chapter, we 
investigated in detail the mechanism of macrophage cell death triggered by B. 
pseudomallei. 
 
TTSS is central to the virulence of many Gram-negative bacteria including Salmonella, 
Shigella, Yersinia and four major genera of plant pathogenic bacteria (Hueck, 1998). 
The components of the secretion and translocation apparatus of different TTSSs are 
structurally conserved in many Gram-negative bacteria while effector proteins largely 
differ from species to species. In the B. pseudomallei genome, there are three loci 
encoding putative TTSSs, two of which have high homology to TTSS of plant 
pathogens. The last locus, named Burkholderia secretion apparatus (bsa), encodes a 
TTSS with high homology to Inv/Mxi-Spa TTSS of animal pathogens (Stevens et al., 
2002). The bsa locus has been shown to modulate intracellular behavior of B. 
pseudomallei in murine macrophages (Stevens et al., 2002). We hypothesize that 
effector proteins encoded by genes in the bsa locus may be responsible for 
macrophage cytotoxicity of virulent B. pseudomallei strains. The bsaQ gene is the 
largest gene encoding a conserved structural component of the secretion apparatus in 
bsa locus. We therefore generated bsa mutants through insertion of a kanamycin 
resistant cassette (KmR) into bsaQ as described in chapter 2. Our aims are to examine 
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the association between bacterial virulence and macrophage killing ability, the role of 
bsa TTSS in the induction of cell death and the mechanism of macrophage cell death.  
 
3.2 MATERIALS AND METHODS 
 
3.2.1 Bacterial strains 
Escherichia coli strain used is KL98. B. pseudomallei ATCC23343, B. mallei 
ATCC23344 and B. thailandensis ATCC700388 (alternative name E264) were 
purchased from American Type Culture Collection (Manassas, VA, USA). All other B. 
pseudomallei strains were isolated from melioidosis patients in local hospitals. Unless 
otherwise stated, the B. pseudomallei strain used in all experiments is KHW, a virulent 
clinical isolate from a local patient who died from melioidosis (Liu et al. 2002). To 
prepare mid-log phase bacteria, 5 mL LB medium was inoculated with 250 μL 
overnight culture and allowed to grow for about 2-3 hours with constant agitation in 
37°C incubator.  
 
3.2.2 Cell lines  
Human monocytic cell line THP-1 and mouse macrophage-like cell line J774 were 
maintained with RPMI 1640 (Sigma), supplemented with 10 % Fetal Calf Serum (FCS, 
Hyclone Laboratories, Logan, UT), 200 mM L-glutamine, 100 Unit/mL penicillin and 
100 μg/mL streptomycin (complete RPMI). Cells were passaged every 3-4 days at a 
ratio of 1:10.  At least 3 hours before infection, culture medium was changed to fresh 
medium with 2 % FCS and without antibiotics. Human lung carcinoma cell line A549 
cells were maintained in DMEM (Sigma) complete media with 10 % FCS.  
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3.2.3 Isolation of monocytes and culturing of dendritic cells and macrophages 
Monocytes were isolated from healthy adult blood donors (National University 
Hospital Blood Donation Centre) essentially as previously described (Cao et al., 2004). 
Briefly, peripheral blood mononuclear cells were isolated from buffy coats using 
Ficoll-Paque Plus (Amersham Pharmacia Biotech, Uppsala, Sweden) and, after 
washing, resuspended in RPMI containing 5 % FCS and allowed to adhere to tissue 
culture plates for 2 hours at 37oC. Non-adherent cells were removed by washing with 
the same media and the adherent monocytes were harvested. Isolated monocytes, 
routinely at approximately 95 % purity, were re-suspended at 1 x 106/ml in complete 
medium. To generate dendritic cells, monocytes were cultured for 6 days in the 
presence of granulocyte and macrophage-colony stimulating factor (GM-CSF) (20 
ng/ml) and IL-4 (20 ng/ml) (R&D Systems Inc., Minneapolis, MN, USA) with half of 
the medium being replaced by fresh medium every other day. Macrophages were 
cultured from isolated monocytes in the presence of macrophage-colony stimulating 
factor (M-CSF) (R&D) for 6 days.  Murine macrophages were isolated from 
thioglycollate inflamed peritoneal cavity of BALB/c, C57BL/6J or caspase-1 knockout 
mice (C57BL/6J background; kind gift from Dr. Richard Flavell, Yale University; 
Kuida et al., 1995). One mL of 3 % Brewer Thioglycollate medium (Difco, Detroit, 
MI) was injected into peritoneum of mouse 5 days prior to cell harvest. Cells were 
pelleted from peritoneal cavity wash and allowed to adhere to 6-well plates (NUNC, 
Roskilde, Denmark) for 3 hours. Adherent cells were then detached carefully with a 
plastic cell scraper (NUNC) and reseeded at appropriate density overnight in complete 
RPMI medium. Adherent cells were washed twice with PBS and culture medium was 
changed to antibiotic free medium before experiments.  Experiments on all types of 
primary cells were performed at least three times in triplicates. 
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3.2.4 Infection and Cytotoxicity assay 
Cytotoxicity was measured by lactate dehydrogenase (LDH) release. For all LDH 
assays, FCS concentration in the medium was reduced to 2 % to reduce background 
LDH activity and medium was free of antibiotics before infection. 2x105 cells (or 
5x105 for primary cells) were seeded in a 48-well plate in 0.6 mL medium per well. 
Mid-log phase bacteria were prepared and added to cells at approximately multiplicity 
of infection (MOI) of 100:1. Tetracycline was added to 40 μg/mL 1 hour after 
infection to suppress the growth of extracellular bacteria. Supernatant was collected at 
8 hours after infection unless otherwise stated. LDH activity in the supernatant was 
measured with Cytotoxicity Detection Kit (Roche) according to manufacturer’s 
instruction. Maximum release was achieved by lysis of untreated cells with 1 % 
Triton-X100 in PBS. LDH activity in supernatant of uninfected cells was taken as 
spontaneous release. Percentage cytotoxicity was calculated with the formula:     
           % cytotoxicity =        Test LDH release  -   spontaneous release .             
                                                         Maximal release-spontaneous release 
All the cytotoxicity assays presented in this chapter were performed with MOI of 
100:1 and cells infected for 8 hours unless otherwise stated. Effect of Ac-YVAD-
CMK (BD Pharmingen), and cytochalasin D (Sigma) at 1 μg/mL was tested by 
addition of these compounds into culture medium 1 hour before infection. Supernatant 
was collected eight hours after infection for LDH assay. For Transwell (Nunc) 
experiments, J774 cells were seeded in a 24-well plate. A Transwell was placed into 
the well before infection. Bacteria inoculated into the Transwell could not come in 
contact with cells, as they were separated by a 0.2 μm membrane. LDH assay was 
performed as before. To determine the IC50 of Ac-YVAD-CMK, THP-1 cells 
pretreated with increasing dose of inhibitors were infected with bacteria. Cytotoxicity 
was plotted against log concentration of the inhibitor. Best-fit curve was then 
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determined by LAB fit Curve Fitting Software (V7.2.31, by Wilton and Cleide P. 
Silva). IC50 was calculated from the curve.  
 
3.2.5 Transmission Electron Microscopy (TEM)  
2x106 infected THP-1 cells or uninfected cells were harvested 4 and 6 hours after 
infection. Samples were fixed in 2.5 % glutaraldehyde in 0.1 M cacodylate/10 mM 
CaCl2 buffer overnight at 4°C then post-fixed with 2 % osmium tetroxide in 100 mM 
sodium cacodylate buffer for 1 hour at 4°C.  Samples were then dehydrated 
sequentially through 30 %, 50 %, 70 %, 90 % and 100 % ethanol, and finally in 
propylene oxide prior to infiltration with spurr resin (Spurr, 1969). Samples were 
embedded in 100 % spurr resin and polymerized at 65°C overnight. Ultra-thin sections 
were cut on a Jung Reichert ultra-microtome and examined with a transmission 
electron microscope (JEM1010, JEOL, Japan) at 100 kV. 
 
 
3.2.6 Cytokine ELISA  
Production of tissue necrosis factor (TNF)-α, mature IL-1β and IL-18 (Bender 
MedSystems, Vienna, Austria) by infected THP-1 cells was measured by ELISA 
according to manufacturer’s instructions. Cells were seeded at 1x106/mL and infected 
as above. Supernatant was collected for ELISA 8 hours after infection.  
 
3.2.7 Caspase activity assay 
Synthetic caspase substrates were purchased from Biomol Research Laboratories 
(Plymouth, PA, USA). Substrates were stored as 20 mM stock solution in DMSO. 
Caspase-2, 3, 8 and 9-like activities in the cell lysate were determined by cleavage of 
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Ac-VDVAD-AMC, Ac-DEVD-AFC, Ac-LETD-AFC or Ac-LEHD-AFC respectively 
as described (Ahmad et al. 2004). Briefly, 1x106 infected or untreated cells were lysed 
with 1 % Triton-X100 in 100 mM phosphate buffer. Then 1 μL of substrate was added 
to 50 μL of cell lysate and 50 μL of 2x reaction buffer. Reaction mixtures were 
incubated at 37°C for 1 hour.  Fluorescence intensity was measured with microplate 
spectrofluorometer (SpectraMAX GeminiXS, Molecular Devices, Sunnyvale, CA) at 
505 nm following excitation at 400 nm for AFC substrates or at 460 nm following 
excitation at 380 nm for AMC substrates. Fluorescence intensity was normalized with 
the protein concentration of the cell lysate and relative caspase activity was calculated 
as fold increase compared to control samples. Staurosporine (Biomol) treated cells 
were included as positive control.  
 
3.2.8 TUNEL assay 
DNA damage was assayed by Terminal deoxynucleotidyl transferase (TdT)-mediated 
dUTP nick-end-labeling (TUNEL) using ApoAlert DNA Fragmentation Assay Kit 
(Clontech, San Diego, CA) according to manufacturer’s instruction. Briefly, control or 
infected cells were fixed with 1 % formaldehyde and then permeabilised with 70 % 
ethanol. After incubation with TdT and nucleotide mix at 37°C for 60 minutes, cells 
were double stained with propidium iodide and analyzed by flow cytometry. THP-1 
cells treated with 1 μM staurosporine for 8 hours were included as positive control. 
For adherent macrophages, TUNEL labeling was performed on slides with similar 
procedures and slides were examined with fluorescent microscope (Olympus, 1x81, 
Japan) with filters for green (520 nm) and red (590 nm) fluorescence.  
 
3.2.9 Polyethylene glycol (PEG) protection assay 
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THP-1 cells were infected with B. pseudomallei in the presence of PEG 200 
(Hydrodynamic radius (Hr) = 0.56 nm), PEG 1000 (Hr =1 nm), PEG 2000 (Hr =1.22 
nm), PEG 3000 (Hr =1.44 nm) and PEG 4000 (Hr =1.92 nm) (Scherrer and Gerhardt , 
1971). Sucrose (Sigma) was included as a control. PEG 200 was from purchased from 
Fluka (Steinheim, Germany) and PEG 1000, 2000, 3000 and 4000 were from 
purchased from Merck (Hohenbrunn, Germany). LDH release was plotted against the 
hydrodynamic radius of the PEG in the medium. Mouse macrophages were infected in 
the absence of PEGs. One hour after infection, cells were washed twice with PBS and 
medium containing 30 mM of various PEGs were added into the well before 
cytotoxicity was determined.  In the control experiments, THP-1 cells were treated 
with 4 μM of staurosporine or 1.6 mM of H O2 2  (BDH, Poole, UK) for 14 hours in the 
presence of 30 mM PEGs before cytotoxicity was determined. Experiments were 
performed at least three times in triplicates.  
 
3.2.10 Intracellular survival of bacteria 
THP-1 cells were infected with wild type B. pseudomallei or bsaQ mutant at an MOI 
of 100:1. One hour after infection, cells were centrifuged at 350g for 3 minutes and 
supernatant was discarded. Subsequently, cells were washed twice with PBS, re-
suspended in medium containing 40 μg/mL tetracycline and seeded at 1x106/mL. Cells 
were lysed 1, 4 or 8 hours after infection. Diluted cell lysates were plated on TSA 
plates, containing 5 μg/mL gentamycin. Colonies were counted after 36 hours.  
Experiments were performed at least three times in triplicates. 
 
3.2.11 Statistical analysis 
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All results were analysed by the Student t-test. p value of less than 0.05 is considered 
significant. 
 
3.3 RESULTS  
 
3.3.1 Virulent Burkholderia pseudomallei strain kills J774 and THP-1 phagocytes 
rapidly  
Macrophage cytotoxicity has been described for many bacterial pathogens including 
Salmonella (Hersh et al., 1999), Yersinia (Monack et al., 1997) and Shigella 
(Zychlinsky et al., 1992). While studying the intracellular behavior of our B. 
pseudomallei strains, we observed that at a high MOI, clinical strain KHW induced 
rapid cell lysis in the human monocyte-like cell line THP-1 cells and the mouse 
macrophage-like cell line J774 (Figure 3.1.1A). Eight hours after infection, at a MOI 
of 100:1, about 40 % of THP-1 cells and 80 % of J774 cells were lysed as measured 
by the release of cytoplasmic protein LDH.  Release of LDH was time-dependent. 
Rate of cell lysis was nearly constant within first eight hours upon infection (Figure 
3.1.1 B). However, infecting cells longer than 8 hours did not significantly increase 
the percentage of cell lysis (Figure 3.1.1 C). Percentage of cell lysis was also 
dependent on bacterial dose (Figure 3.1.1 D). Increasing the dosage of bacteria beyond 
the MOI of 100:1 did not further increase cell lysis probably due to aggregation of 
bacteria at high doses.  In sharp contrast to THP-1 and J774 cells, the same bacterial 
strain was not cytotoxic to A549, a lung epithelial cell line under the same condition 
(Figure 3.1.1 A). This suggests that this bacterial induced cell death is specific to 
monocytic and phagocytic cells. We set out to investigate the mechanism of this death 
and the bacterial factors leading to cell death.  
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Figure 3.1.1 B. pseudomallei induces rapid cell death in phagocytic cell lines. A. B. 
pseudomallei strain KHW killed phagocytic cell lines rapidly but not the epithelial cell 
line. J774, THP-1 and A549 cells were infected with B. pseudomallei KHW at MOI of 
100:1. B. Cell lysis occurred progressively within eight hours. THP-1 cells were 
infected as above. Cell culture supernatant was collected every two hours to 
determined percentage LDH release. C. Infection longer than 8 hours did not increase 
percentage of cell lysis significantly. D. Percentage of cell lysis was bacterial dose-
dependent. THP-1 cells were infected with KHW at MOI of 10, 50, 100 and 500: 1 or 







3.3.2 Cell contact and bacterial invasion are required for killing 
As suggested by Gan et al., B. pseudomallei may secrete toxins to kill nematodes (Gan 
et al., 2002). We investigated the possibility that soluble factors in the bacterial culture 
medium play a role in the induction of macrophage cell death. We had found that 
bacterial culture supernatant added to J774 cells was not cytotoxic nor was heat-killed 
bacteria (data not shown). We then separated bacteria and J774 cells during infection 
using Transwell chambers. Bacteria were not able to penetrate the membrane (pore 
size = 0.2 μm) of the Transwell but secreted factors should diffuse through the 
membrane pores freely. Under this condition, bacteria were not cytotoxic (Figure 3.2.1 
A). We concluded that live bacteria rather than soluble factors in the culture 
supernatant are responsible for induction of cell death and contact between bacteria 
and cell is necessary. However, we are not able to rule out the possibility that soluble 
factors secreted after cell contact may play a role in cell death. We also blocked 
bacteria internalization by cytochalasin D, an actin polymerization inhibitor. It has 
been well-established that cytochalasin D is able to inhibit bacterial invasion of 
mammalian cells and invasion of macrophages by B. pseudomallei can be similarly 
inhibited (Utaisincharoen et al., 2003).  THP-1 cells pretreated with 1 μg/mL of 
cytochalasin D were completely resistant to killing by strain KHW (Figure 3.2.1 B), 




 Figure 3.2.1 Bacterial invasion is required for cytotoxicity. A. Induction of cell 
death was contact-dependent. J774 cells were seeded in 24-well plates. A Transwell 
with 0.2 μm pore size polycarbonate membrane was inserted into each well. Bacteria 
were added into the Transwell at MOI of 60:1. Cell lysis was determined as above at 
various time points after infection. B. THP-1 cells were pre-treated with 1 μg/mL of 















3.3.3 Burkholderia pseudomallei strain KHW kills primary monocytes, 
macrophages and dendritic cells        
To verify if these effects could be extrapolated to primary phagocytic cells, we 
extended our study to include mouse peritoneal macrophages (C57BL/6J), human 
peripheral blood monocytes, human monocyte-derived macrophages (MDM)and 
dendritic cells (MDD). MDM and MDD cells were cultured from monocytes as 
described in the Material and Methods section. B. pseudomallei exhibited 40 % 
cytotoxicity towards monocytes, 50 % to MDM, 70 % to MDD and 60 % to mouse 
macrophages (Figure 3.3.1). These findings strongly suggest that lysis of phagocytic 
cells is not an in vitro artifact with cell-lines, but could be highly relevant in the 
clinical setting and contribute to the pathogenesis of B. pseudomallei infection. As 
macrophages and dendritic cells play important roles in innate immunity and act as 
antigen presenting cells to activate adaptive immunity against bacterial infections, 
early death of these cells would greatly influence the course and outcome of infection. 
However, based on the limited data, it is difficult to predict whether the bacterial 
induced cell death is to the benefit of pathogen or host. It was shown previously that 
BALB/c mice are relatively more susceptible to B. pseudomallei infection than 
C57BL/6 mice (Liu et al., 2002).  To find out whether there is any difference in 
macrophage sensitivity to B. pseudomallei induced killing, we infected macrophages 
from BALB/c mice as well. However, we did not observe any significant difference 
between macrophages from the two strains of mice in terms of bacterial dose response 
and the kinetics of cell lysis (data not shown).  
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 Figure 3.3.1 B. pseudomallei KHW kills primary phagocytes. Human monocytes 
(Mono) were purified from peripheral blood cells. Macrophages (MDM) and dendritic 
cells (MDD) were differentiated from monocytes as described in Materials and 
Methods. Mouse macrophages (MM) were isolated from C57BL/6J mice. Monocytes, 
monocytes-derived macrophages or dendritic cells and mouse peritoneal macrophages 
were infected with KHW at MOI of 100:1. Cytotoxicity was determined after eight 
hours of infection. Experiment with each cell type was repeated for a total of three 
times with cells from independent blood donors or mice. The average and standard 













3.3.4 Macrophage cytotoxicity correlates with virulence of Burkholderia species  
To determine if the ability to kill macrophages and dendritic cells is a peculiar 
property of B. pseudomallei strain KHW, we investigated the ability of various closely 
related Burkholderia species and different B. pseudomallei strains to lyse THP-1 cells, 
the cell-line we chose to use for most of our subsequent assays. B. pseudomallei strain 
KHW is a virulent local clinical isolate (Liu et al., 2002) while strain ATCC15682 is 
another virulent strain isolated from monkey. Strain ATCC23343 has greatly 
attenuated virulence in mice (Ulett et al., 2001). B. thailandensis is a closely related 
but clinically avirulent species (Brett et al., 1997; Brett et al., 1998). B. mallei is the 
causative agent for glanders and is closely related to B. pseudomallei (Godoy et al., 
2003). We observed that at an MOI of 100:1, only virulent B. pseudomallei strains 
were able to induce cell lysis in THP-1 cells within 8 hours (Figure 3.4.1A). These 
data suggest that the ability to kill macrophages is highly species- and strain-specific 
and it is associated with virulent B. pseudomallei strains.  
 
Ten additional clinical B. pseudomallei isolates from patients in local hospitals were 
studied. Five isolates were from fatal cases of melioidosis and the others from non-
fatal cases. However, the virulence of these strains was not defined in animals except 
strain KHW (#22), which has been extensively studied (Liu et al., 2002; Gan et al., 
2002). All the strains showed significant degree of cytotoxicity to THP-1 cells; 
ranging from 10-45 % of cell lysis under similar conditions (Figure 3.4.1 B). On 
average, strains from fatal melioidosis patients had 41.1 % cytotoxicity and strains 
from non-fatal cases had 29.8 %. The difference between these two groups of strains 
was not statistically significant by the Student t-test. As the virulence of these strains 
was not verified in animals, it is probably an oversimplification to group virulence of 
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clinical strains based on their case fatality. The variation in cytotoxicity between 
strains is most likely due to strain specific factors. However, cytotoxicity of these 
disease causing clinical strains is significantly higher than that of avirulent strains and 
that of control E. coil strain. This strong correlation of in vitro macrophage 
cytotoxicity with capability of strains to cause disease suggests that macrophage 






 Figure 3.4.1 Only virulent B. pseudomallei strains are able to induce cell death in 
THP-1 cells. A. THP-1 cells were infected with B. thailandensis, B. mallei, B. 
pseudomallei strain ATCC23343, ATCC15682 and KHW at MOI of 100:1 for eight 
hours. E. coli KL98 was included as control. B. Ten clinical B. pseudomallei isolates 
from patients in local hospital were able to kill THP-1 cells. Strain #8, 12, 22 (KHW), 
23 and 37 were from fatal melioidosis cases (Solid bars); strain #5, 9, 13, 15 and 33 
from non-fatal melioidosis cases (Open bars). Difference between strains from fatal 
and non-fatal cases was not significant (student t test p<0.13). 
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3.3.5 Burkholderia pseudomallei kills macrophages through induction of oncosis 
We had observed swelling of infected cells under light microscope.  To further 
characterize the form of cell death, the morphology of infected THP-1 cells was 
further investigated by TEM (Figure 3.5.1). The nuclei of uninfected cells showed two 
distinguishable lobes, typical of the horseshoe shape nuclei of monocytes (Figure 3.5.1 
A).  In dying cells from infected samples, nuclei were swollen and nuclear material 
appeared diluted (Figure 3.5.1 B).  In the cytosol, swelling of mitochondria and 
vacuoles was clearly evident.  Cells were subsequently lysed probably due to osmotic 
pressure. Nuclei were released apparently intact during cell lysis (Figure 3.5.2). When 
stained with propidium iodide (PI), nuclei released outside the cells were clearly 
evident four hours after infection (Figure 3.5.2 B upper left quadrant).  
 
Apoptosis is characterized by caspase activation, which is responsible for several 
typical apoptotic phenotypes, such as DNA fragmentation (reviewed by Danial and 
Korsmeyer, 2004).  To confirm that the cell death we observed is not due to classical 
apoptosis, we investigated apoptotic caspase activation in infected THP-1 cells by 
several means. Activation of caspase-3 is shown to be negative as quantitated by flow 
cytometry using an antibody against active caspase-3, and Western blot detecting the 
cleavage of pro-caspase-3 to active caspase (data not shown).  Activity of caspases-2, 
3, 8 and 9 in infected cell lysates was measured by cleavage of specific peptide 
substrates labeled with fluorescent dye and found to exhibit no significant changes 
throughout the course of infection. Lack of activation of initiator as well as effector 
caspases during infection was summarized in Table 3.1. DNA damage is often 
associated, although not exclusively, with apoptosis. However, there were less than 5 
% TUNEL positive cells 8 hours after infection, similar to uninfected controls (Figure 
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3.5.3). Together with our results on LDH release by infected cells, these data suggest 
that a significant number of infected THP-1 cells die by a process that more resembles 
oncosis rather than classical apoptosis. In summary, infected THP-1 cells rapidly 
swelled up, lysed and released their cytosolic content and together with apparently 









 Figure 3.5.1 B. pseudomallei killed phagocytes by induction of oncosis. Shown in 
transmission electron micrographs, KHW (B) infected THP-1 cells had swollen cell 
body, nuclei and mitochondria. Uninfected (A) and bsaQ mutant bacteria (C, 
discussed in Section 9 of this chapter) infected cells were included as control. Normal 
mitochondrion (D) from control cells and swollen mitochondrion (E) from KHW 
infected cells were shown. Bacteria bound with (F) or without (G) intact membrane 




Figure 3.5.2 Nuclei were released rapidly during lysis of infected cells. B. 
pseudomallei infected (B) and control (A) THP-1 cells were stained with propidium 
iodide (PI) without permeabilization four hours after infection. In flow cytometry data, 
upper left quadrant of the dot plot represents nuclei released from infected cells. 
Release of nuclei was time dependent (C).  
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 Figure 3.5.3 Bacteria infected THP-1 cells had little DNA fragmentation. Strain KHW  
(thin line) or bsaQ mutant (shadowed) infected cells were labeled with TUNEL kit for 
DNA damage. Uninfected cell were included as control (broken line). Staurosporine 















Table 3.1. Caspase activities in B. pseudomallei infected cells. B. pseudomallei 
infected THP-1 cells were lysed at the indicated time. Caspase activity was presented 
as fold increase relative to uninfected cells. Cell lysate from staurosporine (STS) 
treated THP-1 was included as positive control in all assays. 
 
 Time (min) Caspase-2 Caspase-3 Caspase-8 Caspase-9 
0 1.0 1.0 1.0  1.0 
15 N.D. 0.9 1.1 
 
1.0 
30 1.0 0.9 1.0 1.2 
 45 N.D. 1.0 N. D. 1.1 
60 1.2 1.0 1.2  1.1 
90 1.1 0.9 1.4 
 
1.2 
120 1.1 1.1 1.1 1.0 
 240 1.5 1.1 0.8 1.0 
360 1.8 1.3 0.7  1.0 
STS (120min) 40.3* 10.2 2.2 3.2 
 












3.3.6 Pore-forming toxin is involved in induction of cell lysis  
Rapid but progressive cell lysis is suggestive of pore formation on the cell membrane 
during cell death.   Pseudomonas aeruginosa uses a TTSS dependent pore-forming 
toxin to kill mouse macrophages by oncosis (Dacheux  et al., 2000; Dacheux  et al., 
2001).  It is possible that B. pseudomallei utilizes a similar strategy.  Osmotic cell lysis 
caused by pore forming toxins can be prevented by addition of different-sized 
carbohydrate protectants into the external medium (reviewed by Lobo and Welch, 
1994). We infected THP-1 cells with B. pseudomallei KHW in the presence of 30 mM 
of PEGs of various sizes. Cytotoxicity was analyzed and plotted against the Hr of the 
PEG present in the medium.  As the size of PEG increased, cell lysis decreased from 
85 % to less than 10 % (Figure 3.6.1 A, B). There was a significant drop in LDH 
release, about 25 %, when PEG 3000 was present in the medium, the Hr of which is 
1.44 nm. Cell lysis was almost completely prevented when cells were infected in the 
presence of PEG 4000, Hr of which is 1.92 nm.  Thus the diameter of the pore should 
be similar to that of PEG4000 in solution, which is about 4 nm (2x1.92 nm). In 
comparison, PEG2000 completely inhibited LDH release from retinoic acid 
differentiated U937 cells infected with Shigella (Nonaka et al., 2003). Thus it seems 
that bigger pores were induced by B. pseudomallei than Shigella. The same 
experiment was performed using mouse peritoneal macrophages with similar results 
(Figure 3.6.1A).  In contrast, LDH release induced by high concentrations of H O2 2 or 
staurosporine, which induce necrosis or apoptosis respectively, was not inhibited by 
PEGs (Figure 3.6.1C). These data suggest that pores with uniform size formed on the 
membrane led to cell lysis after B. pseudomallei infection. These pores may be formed 
by bacterial toxins or modified host proteins (Liu et al., 2004). 
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 Figure 3.6.1 Cell lysis is possibly caused by water-permeable pores formed on 
cytoplasmic membrane of infected phagocytes. A. THP-1 cells were pretreated with 
30 mM of polyethylene glycol (PEG) 200, 1000, 2000, 3000 or 4000. For mouse 
macrophages were infected in the absence of PEGs. One hour after infection, bacteria 
were washed away and PEGs were added into medium. Cytotoxicity was plotted 
against the hydrodynamic size of the PEGs presented in the medium. Size-dependent 
inhibition of cell lysis by PEGs was demonstrated in both cells. The same experiment 
was repeated twice for both cell types with similar trend. B. The kinetics of THP-1 cell 
lysis in the presence of 30 mM of indicated PEGs was shown here. Sucrose, a small 
saccharide molecule, was included as control. C. Effect of PEGs on cell lysis induced 





3.3.7 Intact Type III Secretion System is a pre-requisite for cytotoxicity 
We tested the cytotoxicity of bsaQ mutant towards macrophages. bsaQ mutants 
completely lost the ability to kill THP-1 cells (Figure 3.7.1 B).  Stevens et al. had 
shown that bsaZ mutants failed to escape from endosomal vesicles and replicate 
within J774.2 macrophages (Stevens et al., 2002).  It is possible that bsaQ mutants 
were killed in THP-1 cells before they had the chance to induce cell lysis.  However, 
we found that the bsaQ mutant was able to survive inside THP-1 cells for at least eight 
hours (Figure 3.7.1 A). In contrast to published results, for both wild type bacteria and 
bsaQ mutant, membrane bound or apparently free bacteria were readily observed in 
the cytosol of THP-1 4 hours and 6 hours after infection (Figure 3.5.1 F, G and data 
not shown). More studies are needed to define the intracellular location of bsaQ 
mutants in macrophages. Results on primary human monocytes, macrophages and 
dendritic cells are similar to THP-1 cells (Figure 3.7.1 B). These data demonstrated 
that the bsa TTSS is involved in the induction of death either directly through the 
action of bsa-encoded cell death effectors or indirectly by interfering with the escape 
of the bacterium into the cytosol. Within the bsa locus, the bipB gene, encodes a 
protein with high homology (Figure 3.7.2) to Salmonella SipB and Shigella IpaB. 
SipB and IpaB have been postulated to induce macrophage cell death by activating 
caspase-1 (Hersh et al., 1999; Chen et al., 1996). Therefore it is possible that BipB is 
the effector protein secreted through bsa TTSS to induce cell death. Further studies are 
required to define the role of BipB protein. Alternatively, bsa TTSS might mediate the 
endosome escape of the bacterium, which may be a prerequisite for induction of cell 
death. Once inside the cytosol, the bacterium may use other virulence factors to induce 
cell death, which is not necessarily bsa TTSS dependent. 
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Figure 3.7.1 An intact bsa TTSS was needed for full virulence. A. Intracellular 
survival of bsaQ mutant and wild type KHW in THP-1 cells was determined. This 
experiment was performed in triplicates and repeated two times with similar results. 
Wild type bacteria killed THP-1 cell rapidly thus were released into medium. As a 
result, intracellular count for wild type bacteria decreased with time. B. bsaQ was 
unable to induce cell death in THP-1 cells, as well as in monocytes, MDM, MDD and 
mouse macrophages. The negative cytotoxicity value shown for monocytes was due to 
lower amount of LDH released in bsaQ infected cells compared to untreated cells.  
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 Figure 3.7.2 BipB protein has high homology to SipB/IpaB. BipB sequences from B. 
pseudomallei and B. thailandensis were aligned with SipB and IpaB. BipB of B. 
mallei is identical with that of B. pseudomallei. Strictly conserved residues were 






3.3.8 Potent inflammatory cytokines are released during cell lysis 
During B. pseudomallei infection, THP-1 cells were found to secrete inflammatory 
cytokines, namely TNF-α, IL-1β (Figure 3.8.1 A) and IL-18 (Figure 3.8.1 B). IL-1β 
and IL-18 are produced as inactive form, pro-IL-1β and pro-IL-18 respectively (Black 
et al., 1989; Kostura et al., 1989), and stored in the cytosol. The increase in cytokines 
measured at eight hours after infection could also be due to the lysis of cells, thereby 
releasing intracellular cytokines.  It is important to note that the ELISA kits we used to 
measure IL-1β and IL-18 only detect processed and mature cytokines.  Although the 
production of TNF-α is not adversely affected by the bsa mutation, production of IL-
1β and IL-18 was dependent on the bsa locus, as bsaQ mutant infected cells secreted 
ten-fold less IL-1β and IL-18.  This shows that bsa TTSS-dependent effectors are 










 Figure 3.8.1 Inflammatory cytokines are release during bacterial induced cell lysis. 
TNF-α (A. filled bar), IL-1β (A. open bar) and IL-18 (B) released by THP-1 cells 
were measured eight hours after KHW infection. As controls, cells were also treated 

















3.3.9 Caspase-1 is required for rapid induction of cell lysis 
Since mature IL-1β and IL-18 were detected during B. pseudomallei induced 
macrophage death, it implies that the caspase-1 was activated during cell death. As 
expected, inhibition of caspase-1 by synthetic inhibitors greatly reduced the 
production of IL-1β (Figure 3.9.1 A, open bar).  In addition, cell lysis was also 
decreased in the presence of caspase-1 inhibitor (Figure 3.9.1 A, solid line). The IC50 
of the inhibitor was determined to be 10.6 μM for THP-1 cells (Figure 3.9.1 B). This 
suggests that caspase-1 plays an important role in the B. pseudomallei induced 
macrophage cell death. In fact, caspase-1 mediated macrophage cell death has been 
well characterized for several pathogens, including Shigella (Chen et al., 1996), 
Salmonella (Hersh et al., 1999), and recently anthrax toxin (Boyden and Dietrich, 
2006). We further tested the effect of caspase-1 inhibitor on primary cells. Caspase-1 
inhibitor reduced 20 % of the bacterial induced cell lysis in human MDM and mouse 
macrophages, but it has no effect on human peripheral blood monocytes (Figure 3.9.1 
C). This discrepancy might be due to different mechanisms of cell death or differential 
permeability of the same inhibitors on monocytes and macrophages. To clarify the role 
of caspase-1 in B. pseudomallei induced macrophage cell death, we used macrophages 
isolated from genetically modified mice. Peritoneal macrophages isolated from 
caspase-1 knockout mice or wild type mice were infected with different doses of B. 
pseudomallei strain KHW and cytotoxicity measured as before. As shown in Figure 
3.9.1 D, caspase-1 null macrophages were resistant to killing compared to normal 
macrophages. With MOI of 100:1, about 15 % of caspase-1 KO macrophages were 
lysed compared to 50 % of wild type cells. We concluded that caspase-1 is necessary 
for the induction of oncosis in B. pseudomallei infected macrophages.  
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Hypoxia induced oncosis can be inhibited with glycine, which binds to glycine gated 
chloride channel (Lemasters et al., 2002). We tested the effect of glycine in our system.  
Glycine inhibited about 40 % of bacterial induced LDH release in MDM and MM 
(Figure 3.9.1.C open bar). However, the inhibitory effect was less obvious in THP-1 
cells and not observed in human monocytes. Thus more work is needed to clearly 











 Figure 3.9.1 B. pseudomallei induced macrophage oncosis is caspase-1 dependent. 
A. Caspase-1 inhibitor Z-YVAD-FMK reduced IL-1β production as well as LDH 
release from THP-1 cells. B. B. pseudomallei induced LDH release from THP-1 cells 
pretreated with increasing amount caspase-1 inhibitor Ac-YVAD-CMK. Half 
inhibitory concentration (IC50) value calculated from the curve was 10.6 μM. C. 
Caspase-1 inhibitor and glycine have variable effects on LDH release induced by B. 
pseudomallei in human monocytes, human monocytes derived macrophages (MDM), 
mouse macrophages (MM) and THP-1 cells. Relative cytotoxicity was calculated by 
dividing the cytotoxicity of inhibitor treated cells with that of solvent treated cells. D. 
Caspase-1 KO macrophages were more resistant than wild type cells to B. 





3.3.10 Caspase-1 independent macrophage apoptosis 
As discussed previously, LDH release could still be detected from caspase-1 KO 
macrophages when infected with high MOI, though it was significantly reduced 
(Figure 3.9.1 D). We decided to examine this apparently delayed cell lysis. Upon 
careful observation, we found that these cells showed characteristic apoptotic bodies 
and cell shrinkage after infection (Figure 3.10.1 B, white arrowhead). These cells had 
fragmented DNA as they were TUNEL positive (Figure 3.10.1 B, white arrowhead), 
which is consistent with apoptotic phenotype. In contrast, bacterial infected wild type 
macrophages had round up cell bodies and nuclei (Figure 3.10.1 A, black arrowhead), 
which is similar to THP-1 cells (Figure 3.5.1 B).  The apoptotic phenotype could be 
observed as early as 2 hours after infection (data not shown). In the early stage of 
apoptosis, plasma membrane is intact. Only in the late stage of apoptosis in vitro, cells 
lost plasma membrane integrity and release their cytoplasmic content. Many of the 
apoptotic cells may still maintain intact cytoplasmic membrane in the early phase of 
infection. This explains the apparent late release of LDH in these cells. Thus it is 
worthwhile to point out that the percentage of LDH release were likely lower than the 
real percentage of cell death (Figure 3.9.1D). Apoptosis specific quantitative assays 
are needed to measure the percentage of cell death. This form of cell death may 
represent one of pathogen induced caspase-1-independent macrophage cell death 
(C1IMD). 
 
Since caspase-1 dependent cell death requires the function of bsa TTSS, we also tested 
the ability of bsaQ mutant to kill caspase-1 KO macrophages. Under the same 
condition, bsaQ infected cells remain viable while wild type bacteria induced 25 % 
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LDH release 8 hours after infection (Figure 3.10.1; Figure 3.10.2). Therefore bsa 
TTSS is still required for C1IMD. 
 
Activation of apoptotic caspases is the hallmark of apoptosis. To clearly demonstrate 
C1IMD is indeed through apoptosis, we measured caspase-3 activation. Consistent 
with THP-1 cells, wild type macrophages showed no sign of caspase-3 activation after 
B. pseudomallei infection (Figure 3.10.3 A). In contrast, in caspase-1 KO 
macrophages, ten-fold increase in caspase-3 activity was observed as early as 2 hours 
after infection, and it peaked at 4 hours (Figure 3.10.3 B). Together with the 
observation of apoptotic phenotype described above, we concluded that B. 





  Figure 3.10.1 TUNEL staining of B. pseudomallei infected macrophages. Wild type 
(A) or caspase-1 KO macrophages (B) grown on the glass slides were infected with B. 
pseudomallei KHW and bsaQ mutants for 6 hours before being fixed with 4 % 
formaldehyde. Untreated and STS treated cells were included as controls. Cells were 
labeled with TUNEL for DNA damages (green). Cells were counter stained with PI 
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(red) to visualize nuclei. The first column of A and B is phase-contrast images and the 
second is overlay of green and red staining of the same view. White arrowheads 
indicate apoptotic nuclei and black arrowheads oncotic nuclei.   
 
 
Figure 3.10.2 bsaQ mutant was not able to kill caspase-1 KO macrophages. Caspase-1 
KO macrophages were infected with wild type and mutant B. pseudomallei. LDH 
release was determined 8 hours after infection.  
 
 
Figure 3.10.3 Caspase-3 activation in B. pseudomallei infected caspase-1 KO 
macrophages. Caspase-3 activity was measured in B. pseudomallei KWH infected 
wild type (A) and caspase-1 KO macrophages (B). STS treated cells were included as 




3.4.1 Pyroptosis  
In the last decade, pathogen induced caspase-1 dependent macrophage cell death has 
been gradually recognized as a unique form of programmed cell death. This type of 
cell death was described as apoptosis, oncosis, and necrosis in various reports 
(reviewed by Haimovich and Venkatesan, 2006). However, a new term, pyroptosis, 
has recently been coined to better differentiate this form of cell death from other forms 
(Cookson and Brennan, 2001; Fink and Cookson, 2005). Two most well established 
models of pyroptosis are Shigella and Salmonella induced macrophage cell death. 
Caspase-1 was previously known as interleukin-1β converting enzyme (ICE), which 
was discovered by its ability to process the pro-IL-1β to its mature form. It belongs to 
the inflammatory caspase family, which includes human caspase-4, 5 and mouse 
caspase-11 and 12 (Martinon and Tschopp, 2004). Caspase-1 as well as other 
members of the family was thought previously not to be involved in cell death as 
caspase-1 KO mice developed normally and caspase-1 deficient cells responded 
normally to known apoptosis inducers. However, it was later found that over 
expression of caspase-1 can trigger cell death. Most importantly, over activation of 
caspase-1 by several pathogenic bacteria led to macrophage cell death.  This form of 
cell death depends on host proteins but is different from classical apoptosis in at least 
three prominent ways. Firstly, it does not depend on any of classical apoptotic 
caspases, including caspase-2, 3, 8 and 9. Activation of conventional caspases cannot 
be detected during caspase-1 activation. Secondly, dying cells lose membrane integrity 
rapidly and release their cytosolic content. Thirdly, it is highly inflammatory. Potent 
inflammatory cytokines including IL-1β and IL-18 are released as a result of caspase-1 
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activation. Other phenotypic descriptions of pyroptosis reported in the literature were 
confusing. Features like DNA fragmentation, nuclear condensation, and ability of 
synthetic inhibitors to prevent cell lysis were reported in some but not other studies 
(reviewed by Haimovich and Venkatesan, 2005). In the data presented here, we have 
described the mechanism of cell death induced B. pseudomallei in THP-1 cells as well 
as mouse macrophages. This mode of cell death has all the three unique features of 
pyroptosis. Accordingly, activation of classical caspases was not observed in bacterial 
infected THP-1 cells (Table 3.1.) and mouse macrophages (Figure 3.10.3A). Infected 
THP-1 cells, mouse macrophages and several other cells rapidly lost membrane 
integrity (Figure 3.1.1 and 3.3.1). Most importantly, a clear dependence on caspase-1 
was demonstrated with cells from genetically modified animals (Figure 3.9.1). Oncotic 
swelling was also evident in infected macrophages (Figure 3.5.1 and 3.10.1). However, 
we were not able to define the causal relationship between pore-formation and 
caspase-1 activation yet.  
 
3.4.2 Physiological significance of macrophage cell death: good or bad to host? 
Pyroptosis may represent one aspect of innate immunity protecting the host against 
invading pathogens. Infection of wild type mice with Shigella flexneri results in severe 
inflammation (Sansonetti et al., 2000). However, within one to two days, the 
inflammation is significantly reduced, and the infection is eventually resolved. In 
contrast, caspase-1 KO mice develop delayed inflammation and ultimately succumb to 
infection. On the other hand, pathogens may also take advantage of the detrimental 
effect of the strong inflammation to invade the host more efficiently. Thus oral 
infection of wild type mice with Salmonella typhimurium results in human typhoid-
like systemic infection. However, the caspase-1 deficient mice are highly resistant to 
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the same oral bacterial infection, suggesting that caspase-1 mediated inflammatory 
response is in favor of the bacterium (Monack et al., 2000). Acute necrotizing 
inflammation with infiltrating neutrophils and macrophages in lungs of melioidosis 
patients is a common feature of acute disease (Wong et al., 1995). The same scenario 
can be seen in the murine intranasal infection model where susceptible BALB/c mice 
exhibit high bacterial loads (Liu et al., 2002) in the lung and spleen with massive 
infiltration of neutrophils and macrophages (Koo G. C. and Gan Y. H., unpublished 
data). It is very possible that caspase-1 dependent macrophage death contributes to 
local inflammation and tissue damage in vivo. One of the cytokine secreted, IL-18, can 
promote the production of IFN-γ, which has been shown to be essential for resolving 
of B. pseudomallei infection (Santanirand et al., 1999). However, it remains unknown 
whether caspase-1 dependent inflammation helps control infection as in the case of 
Shigella infection, or the overwhelming inflammation facilitates systemic spread of B. 
pseudomallei. We have observed that B. pseudomallei killed macrophages from 
BALB/c and C57BL/6J mice with equal efficiency although BALB/c mice are 
susceptible while C57BL/6J mice relatively resistant to infection. Thus it is likely that 
additional host specific factors tilt the balance between beneficial and deleterious 
effects of the inflammation resulting in differential susceptibility to B. pseudomallei 
infection.  
 
3.4.3 Role of BipB: the controversy  
BipB protein is a homolog of IpaB/SipB from Shigella/Salmonella respectively. The 
function of IpaB and SipB has been extensively studied. Both proteins possess 
multiple functions. IpaB/SipB together with IpaC/SipC are translocators. They are 
able to insert themselves into host cell membrane after being secreted through TTSS 
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and forming a pore to facilitate the entry of other effectors. It was demonstrated that 
purified IpaB/SipB formed a trimer in vitro and inserted into mammalian cell 
membrane or artificial phospholipid bilayers (Hayward et al., 2000; Hume et al., 
2003). IpaB/SipB is required for activation of caspase-1 in bacterial infected 
macrophages. However, as ipaB/sipB mutant is defective in secretion of any effector 
proteins, it is very difficult to clearly define the function of IpaB/SipB using ipaB/sipB 
mutant. It has been shown in vitro that both proteins can bind directly to caspase-1 and 
induce its self-activation (Chen et al., 1996; Hersh et al., 1999). However, the 
significance of this binding in vivo is still not convincing (reviewed by Hueffer and 
Galan, 2004). We have shown that intact bsa TTSS is required by cytotoxicity. In 
view of the 70 % of homology shared between BipB of B. pseudomallei and 
IpaB/SipB protein (Figure 3.7.2), it is tempting to suggest that BipB has the similar 
role as IpaB and SipB in caspase-1 activation. On the other hand, it would be difficult 
to demonstrate conclusively whether BipB activates caspase-1 directly. The matter is 
further complicated by the fact that proteins with identical or highly similar sequence 
are present in B.  mallei and B. thailandensis respectively, yet these two bacteria are 
not cytotoxic to THP-1 cells (Figure 3.4.1A). The discrepancy cannot be attributed to 
differential survival within macrophages. Both bacteria have been shown to survive 
and move within J774.2 macrophages using similar actin-binding proteins (Stevens et 
al., 2005a; Stevens et al., 2005b). In conclusion, though BipB is the prime candidate 
for the activator of caspase-1, it remains possible that other effectors contribute to 
caspase-1 activation in conjunction with BipB or independent of BipB.  
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3.4.4 Bacteria induced caspase-1 activation 
Caspase-1 cleaves pro-IL-1β and pro-IL18 to their mature form. Caspase-1 itself is 
expressed as a zymogen in the cytosol as all the other caspases.  It was not known how 
caspase-1 is activated until recently. Soon after the discovery of NACHT-, LRR-, and 
PYD-containing proteins (NALP), a family of multi-domain proteins, it was shown 
that NALP1 is the part of a multi-protein complex termed an inflammasome (Martinon 
et al., 2002). In this complex, NALP1 recruits and activates caspase-1 via an adaptor 
protein ASC. In the following years, several bacterial pathogens and microbial 
products were found to able to trigger the assembly of inflammasome (Figure 3.11.1). 
Salmonella activates caspase-1 through the Ipaf and ASC dependent pathway 
(Mariathasan  et al., 2004; Mariathasan et al., 2006; Miao et al., 2006; Franchi et al., 
2006), Francisella through ASC but not Ipaf (Mariathasan et al., 2005; Mariathasan et 
al., 2006), Listeria and Staphylococcus through NALP3 and ASC (Mariathasan et al., 
2006), and anthrax lethal toxin through NALP1 pathway (Boyden and Dietrich, 2006). 
As discussed above, B. pseudomallei induced caspase-1 dependent macrophage death 
resembles that by Salmonella. We would predict that B. pseudomallei activates 
caspase-1 through the Ipaf/ASC inflammasome. Further studies are needed to confirm 
our prediction. Our macrophage killing system can be employed to study the assembly 
and activation of inflammasome.  
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3.4.5 Bacterial induced caspase-1-independent macrophage cell death  
The mechanism of bacterial induced C1IMD is not well studied. Several reports 
showed that inhibition of MAPK after bacterial infection leads to macrophage 
apoptosis (Hsu et al., 2004; Park et al., 2002). Pathogen associated molecular patterns 
(PAMPs), such as LPS, activate Toll-like receptors (TLRs), which leads to activation 
of both pro-apoptotic and MAPK dependent anti-apoptotic responses. However, with 
the help of MAPK-inhibiting bacterial toxins such as YopJ of Yersinia, bacterial 
infection leads to rapid macrophage apoptosis. The physiological significance of this 
form of apoptosis is not entirely understood. Recent studies on Mycobacterium 
suggest that bacterial induced macrophage apoptosis enhances the presentation of 
bacterial antigens associated with apoptotic bodies through detour pathway (Schaible et 
al., 2003). Thus, vaccine strains inducing more macrophage apoptosis trigger greater 
immune response and have better protective effect after vaccination (Winau et al., 
2004; Winau et al., 2005). The same mechanism may work during B. pseudomallei 
infection of host with mutations in caspase-1 or caspase-1 activating adaptors. It might 
be worthwhile to examine antigen-specific T cell response in caspase-1 KO mice and 
compared it with that from wild type mice.  
 
3.4.6 Pore forming toxin: what is it? 
We have shown pores of uniform size being formed on the cell membrane during cell 
lysis. Cell lysis can be prevented by osmoprotectants in the medium. Increased 
membrane permeability and possible involvement of pore-forming toxin were reported 
before in Shigella (Nonaka et al., 2003) and Pseudomonas aeruginosa infection 
(Dacheux et al., 2001). Translocators of TTSS are inserted into cytoplasmic 
membrane and presumably endosomal membrane to facilitate the delivery of other 
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effectors. Indeed, purified IpaB and SipB can insert into artificial membranes, but 
membrane insertion does not disrupt the membrane integrity in vitro (Hayward et al., 
2000; Hume et al., 2003). It is possible for BipB to have similar function, but again it 
remains a speculation. In one report, many B. pseudomallei clinical isolates were 
found to produce hemolysin in vitro (Ashdown and Koehler, 1990). It is possible that 
hemolysin or other cytolytic bacterial toxin participate in the pore formation.  
 
In summary, I have described a novel mechanism employed by B. pseudomallei to 
evade macrophage killing by inducing caspase-1 dependent oncotic cell death, or 
pyroptosis. As pyroptosis has been reported in several other well-studied infection 
models, we can take advantage of the knowledge in these models to deepen our 
understanding on the pathogenesis of B. pseudomallei. Our system can also be 
employed to study inflammasome formation, which is the crucial control step in 

















Tn5 based transposons have been used extensively for the genetic analysis of Gram-
negative bacteria. Tn5-OT182 was designed with features to facilitate the 
characterization process (Merriman and Lamont, 1993). In the original report, it was 
used successfully to isolate pyoverdine-deficient mutants in Pseudomonas aeruginosa. 
Subsequently, it was shown that this modified Tn5 transposon could be used in B. 
pseudomallei (DeShazer et al., 1997; Gan et al., 2002; Pilatz et al., 2006).  
 
Caspase-1 dependent macrophage cell death and the proinflammatory outcome are 
likely to play a role in the pathogenesis of bacterial infection. Since we have 
established a role for the bsa TTSS in macrophage cytotoxicity, we are interested to 
identify the specific bsa TTSS-dependent effectors that are involved in the killing of 
macrophages. Screening of a transposon library of bacterial mutants is a convenient 
way to identify novel proteins with a specific function. We explore the feasibility of 
identifying virulence factors involved in macrophage cytotoxicity by screening a 
transposon library for mutants with attenuated macrophage cytotoxicity.  Previously, 
our group managed to identify several bacterial virulence factors using the 
Caenorhabditis elegans host system (Gan et al., 2002). However, the screening 
procedure based on the worming killing assay is tedious and time consuming as 
bacterial mutants have to be inoculated one by one onto individual plates of worms 
and then the number of dead and live worms counted for each plate. In contrast, the 
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cell culture based macrophage killing assay can be performed in a 96-well format with 
potentially high efficiency. In addition, putative mutants can be characterized in detail 
using the macrophage killing model in terms of cell invasion, intracellular replication 
and signaling directly.   
 
In this study, we aim to develop an efficient screening protocol based on the 
macrophage killing assay to identify effectors involved in macrophage cytotoxicity 
and caspase-1 activation. In a small-scale screening, we identified several transposon 
mutants with attenuated macrophage cytotoxicity.  
 
4.2 MATERIALS AND METHODS 
 
4.2.1 Filter conjugation  
Transposon carrier plasmid pOT182 (CmR GmR R RAp Tc , GI:3282100) was maintained 
in E. coli SM10 (thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu KmR). 
SM10/pOT182 was grown on LB agar or LB broth with 20 μg/mL gentamycin or 10 
μg/mL tetracycline. pOT182 was introduced into B. pseudomallei via filter 
conjugation (DeShazer et al., 1997; Gan et al., 2002). Five mL of E. coli 
SM10/pOT182 and B. pseudomallei KHW were grown overnight in LB in 37°C 
incubator. 200 μL of overnight culture of each strain was added into 3 mL of pre-
warmed 10 mM MgSO4 in 50 mL tube. The bacterial mixture was centrifuged at 3000 
g for 3 minutes. The supernatant was removed and bacteria were re-suspended in 500 
μL of 10 mM MgSO4. The bacterial mixture was then filtered through 0.45 μm pore 
nitrocellulose filter (Millipore Corporation, Bedford) placed in a cell strainer (Becton 
Dickinson Labware, USA) in 50 mL tube. A brief centrifugation was performed to 
 92
remove excess liquid. The filter paper was transferred onto LB agar supplemented 
with 10 mM and incubated at 37°C for exactly 8 hours. Bacteria were washed off the 
filter with 2 mL of 0.85 % NaCl. Aliquots of 180 μL were plated onto TSA agar with 
100 μg/mL streptomycin and 50 or 70 μg/mL of tetracycline for 36 hours. All the 
positive clones were grown and stored in 96-well plates.  
 
4.2.2 Colony PCR 
To examine the efficiency of transposon integration, crude DNA was prepared from 
colonies and screened by PCR for the presence of tetA gene. A small amount of 
bacteria was scraped from individual colonies, re-suspended in 20 μL 1 mM NaOH 
and heated at 95°C for 10 minutes. For PCR, 1 μL of crude DNA extract was used as 
template for a reaction of 10 μL. The PCR was performed with Taq DNA polymerase 
(Promega). The primers used are TetF1 5’-CAGACGTGAAACCCAACATAC-3’ and 
TetR1 5’-GTTTCCACGATCAGCGATC-3’. PCR reaction mixture contained 1x 
buffer, 0.4 μM of each primer, 1.5 mM MgCl2, 200 μM of dNTP, 0.2 unit of 
polymerase. Cycling parameters were, 95°C for 4 minutes, followed by 35 cycles at 
95°C for 1 minute, 50°C for 1 minute, and 74°C for 1 minute and a final extension at 
72°C for 10 minutes. The size of the product is 1.2 kb.  
 
4.2.3 Screening macrophage cytotoxicity mutants 
The screening procedure is illustrated in Figure 4.2.1. The transposon mutants were 
inoculated from the storage plates into new 96-well plates with 200 μL LB in each 
well containing 40 μg/mL of tetracycline. Bacteria were grown overnight and diluted 
10 times in fresh LB and grown for another 2 hours before infection. THP-1 cells were 
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seeded at 5x104 cells per 100 μL medium per well in 96-well plates two hours before 
infection in antibiotic free RPMI medium. 10 μL of bacteria from each well of the 
plate was inoculated into the corresponding well in the THP-1 plate. One hour after 
infection, 200 μg/mL of kanamycin was added to each well to suppress the 
extracellular bacterial growth. Six hours after infection, THP-1 cells were observed 
under inverted light microscope. With 20 x 40 magnifying power, one visual field 
contained approximately 100 cells under the experimental condition. If oncotic cells 
were easily spotted (>10 cells found), the corresponding mutant inoculated was not 
considered for further studies. If less than 10 oncotic cells were found in any three 
non-overlapping fields, the mutant inoculated was chosen for second round of 
quantitative screening. Cytotoxicity of mutants found in first round of screening on 
THP-1 cells and mouse macrophages was measured as percentage of LDH release as 
described in chapter 3. Peritoneal macrophages were isolated from BALB/c and 
C57BL/6 mice as described in chapter 3.  
 
4.2.4 Characterization of transposon mutants 
Genomic DNA was isolated from mutants using method decribed in chapter 2. 250 ng 
of DNA of each mutant was digested with BamHI (B), EcoRI (E), HindIII (H) or NotI 
(N) overnight at 37°C before. The restriction enzymes were heat-inactivated by 
incubating at 75°C for 15 minutes. 60 ng of sample was ligated with T4 ligase at 15°C 
for 16 hours. Ligation product was purified using PCR purification kit (Qiagen, GmbH, 
Germany) to remove salt. 10 ng of purified ligation product was transformed into 
DH5α competent cells via electroporation.  Positive transformants were selected with 
5 μg/mL of tetracycline or 100 μg/mL ampicillin. Plasmids recovered from positive 
clones were sequenced with primer OTF1 5’- CTGGAAAACGGGAAAGGTTC-3’. 
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OTF1 has binding site on both ends of the transposon as shown in Figure 4.3.1. 
Sequences obtained were sent through BLAST against the B. pseudomallei K96243 
genome on genomic BLAST server at 
http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi?database=272560. Position of the 
transposon insertion site was located with the help of Vector NTI software (Informax 
inc.).   
 
4.2.5 Motility assay  
Motility of the B. pseudomallei mutants was examined on soft agar. 10 μL of 
overnight culture was stab-inoculated onto TSB (Difco, BD) plates containing 0.3 % 
agar using a micropippetor. After incubation at 37°C overnight, plates were checked 
and photographed.  
 
4.2.6 Western blot 
Western blot was performed as described in chapter 2. The blot was probed with anti-
flagellin polyclonal mouse serum (1:100, generated previously by Koo G.C.) and 
detected with horseradish peroxidase-conjugated goat anti-mouse IgG (1:10,000, 
Sigma).  
 
4.2.7 Statistical analysis  








4.3.1 Generation of random transposon mutants 
To create random transposon mutants of B. pseudomallei, we used a modified Tn5 
transposon, which has been used successfully on this bacterium (Gan et al., 2002). The 
mobilisable suicide plasmid pOT182 is the carrier plasmid of this transposon (Figure 
4.1.1, Merriman and Lamont, 1993). It was maintained in E. coli SM10. The plasmid 
was introduced into B. pseudomallei KHW via filter conjugation as described in 
Materials and Methods section. Exconjugants were plated on selection agar with 200 
μg/mL of streptomycin and 50 μg/mL of tetracycline for 48 hours. However, under 
this condition, many resulting colonies (18/20) were false positives as they were PCR 
negative for the tetA gene of the transposon (Figure 4.1.2, first two panels). When 
tetracycline concentration on the selection agar was increased to 70 μg/mL, all the 
colonies (12/12) were positive for tetA gene (Figure 4.1.2, third panel). This new 
selection condition was used in all the subsequent experiments and colonies were 




Figure 4.1.1 pOT182, transposon carrier plasmid. pOT182 plasmid contains Tn5-
OT182 transposon, a modified Tn5. Gene products of traK, traJ and tralp allow the 
plasmid to be introduced into Gram-negative bacteria by conjugation. There are two E. 
coli specific replication origins on the plasmid. The ori present in the middle of 
transposon facilitates the cloning of DNA adjacent to Tn5. Neither of the replication 




 Figure 4.1.2 Optimization of tetracycline concentration for selection of transposon 
positive mutants on agar. After conjugation on the filter for 8 hours, bacteria were 
plated on selection agar containing 100 μg/mL of streptomycin and 50 or 70 μg/mL of 
tetracycline. After 48 hours, positive colonies were screened for the presence of tetA 

















4.3.2 Screening for macrophage cytotoxicity mutants 
To establish an efficient and reliable screening protocol based on the cytotoxicity 
assay, we tried several quantitative methods using THP-1 cells in microtiter plate 
format. We first tried to measure LDH release after infection of THP-1 cells in 96-well 
plates. However, this method required separation of cultured medium from cells and 
addition of assay solution and stop solution. Extensive manipulation increased 
workload greatly and amplified the risk of cross contamination. We then attempted to 
measure cell survival instead as only one step of dye addition was necessary using the 
MTT based cell proliferation assay kit. As only about 40 to 50 % of THP-1 cells were 
killed by eight hours (Figure 3.1.1 A), the remaining live cells gave rise to high 
background in this survival assay. Despite a lot of effort made in optimization of the 
assay, differences between wild type and non-toxic bsaQ mutant were small and not 
reproducible. Furthermore, variation of growth rate of mutants on 96-well plates made 
normalization of inoculum for each mutant impractical to achieve. As we have shown 
in the previous chapter, cytotoxicity was dose dependent (Figure 3.1.1 D). This 
additional variation contributed to non-reproducibility of the assay. In summary, 
without the help of automated or semi-automated devices, it is a challenge to design an 
efficient quantitative assay based on cell killing to screen a large library of mutants.  
  
We decided to add a qualitative scrutinization step to reduce the number of mutants 
we needed to handle in a quantitative assay. As discussed in the last chapter, wild type 
B. pseudomallei killed 40-50 % of THP-1 cells rapidly. The phenotype of oncotic 
THP-1 cells, swollen and transparent cell bodies (Figure 3.5.1 B), were easily spotted 
and differentiated from viable cells under the light microscope. In contrast, bsaQ 
mutant was completely avirulent. It was hard to find any oncotic cells even after 
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careful examination of an entire well containing 5x104 cells. Based on this fact, we 
chose to pick out mutants with the most severely attenuated cytotoxicity for further 
analysis by visual discrimination. THP-1 cells on a 96-well plate were infected with a 
library of transposon mutants for 6 hours. Cells were then observed under light 
microscope. With 5x104 cells in 100 μL of medium per well, under 20×40 magnifying 
power, each field contained roughly 100 cells. If more than 10 oncotic cells were 
easily spotted in one microscopic field, then the mutant inoculated to this well would 
not be considered for further analysis. If it was difficult to find more than 10 oncotic 
cells in three non-overlapping field of one well, the mutant inoculated to the well 
would be marked as putative cytotoxicity mutants. It took not more than 30 minutes to 
examine one plate. Routinely, 3 to 10 mutants were picked out from each 96-well 
plate examined. Within one month, we screened about 1000 mutants (11 96-well-
plates) and picked out 25 clones for further analysis by quantitative LDH assay. We 
infected THP-1 cells with each of the 25 clones with an approximate MOI of 100:1 in 
triplicates. Supernatant was harvested for LDH assay. Among the 25 mutants, 18 
showed significant attenuation in cytotoxicity to THP-1 cells (Figure 4.2.2 A). One of 
them, OT8C4, had an apparent slower growth rate in liquid broth and was excluded 
from further analysis. The rest of 17 clones were tested again on mouse macrophages. 
As mouse macrophages were more sensitive to B. pseudomallei infection, only 8 out 
of 17 mutants showed significant attenuation (Figure 4.2.2 B). We validated the 
cytotoxicity attenuation of the 8 mutants again in THP-1 and mouse macrophages 




In summary, we established a three step screening protocol to identify macrophage 
cytotoxicity mutants from a random transposon library (Figure 4.2.4).  Using a 
combination of qualitative and quantitative procedures, we were able to efficiently 
identify 8 mutants out of a library of 1000 mutants. The first visual screening step, 
which took advantage of the distinct oncotic phenotype induced by wild type B. 
pseudomallei, allowed us to quickly narrow down our focus on a very small number of 
mutants with the most severe phenotypic attenuation. Two further rounds of 












Figure 4.2.1 Visual screening of mutants with most severe attenuation of cytotoxicity 
to THP-1 cells. Mutants cultured in a 96-well plate were inoculated onto a plate of 
THP-1 cells. 6 hours after infection, cells were examined under light microscope. 






Figure 4.2.3 Second round confirmation LDH assay. Eight visually screened mutants 
were tested for their cytotoxicity by LDH assay in THP-1 cells (A) and mouse 
macrophages (B). The bacterial inoculum for all strains was normalized by their 
optical density. Estimated MOI was 100:1 for all strains. The experiment was done in 
triplicates. The difference of cytotoxicity between mutants and wild type in both 
experiments was statistically significant with p value of less than 0.05.  
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 Figure 4.2.4 Screening efficiency chart. Size of the circle and the number in the 
middle represented the number mutants handled in each step. The fold of reduction in 
mutant number was shown for each step. Overall, we selected 8 mutants out of a pool 


















4.3.3 Characterization of mutants 
Transposon Tn5-OT182 has an ori contained within the transposon sequences, which 
facilitates the self cloning of partial transposon with adjacent DNA (Figure 4.1.1) in E. 
coli. By sequencing the cloned plasmid and aligning the sequence with the sequence 
of B. pseudomallei genome, the insertion site of transposon can be easily identified. 
We extracted genomic DNA from the 8 transposon mutants (Table 4.1). Then they 
were digested with BamHI, EcoRI, HindIII or NotI. Digested DNA was re-ligated and 
transformed into E. coli DH5α by electroporation. Plasmids isolated from tetracycline 
resistant transformants were sequenced with OTF1 primer. At least two independent 
sequences were obtained for all mutants except OT5A2. Then sequences were blasted 
against the fully annotated B. pseudomallei genome on Genbank. In this way, the 






 Figure 4.3.1 Characterization of transposon mutants. A. Tn5-OT182. Restriction 
enzyme sites were indicated on the transposon. There is a primer-binding site for 
OTF1 on each end of the transposon. B. Flow chart illustrating the process of 
characterization. The arrow represents Tn5-OT182. Arrowheads mark the position of 
restriction sites, one on the transposon and one on the adjacent genomic sequence. 
Cloned plasmids were named after the mutant clone number (ID) and the restriction 








To our surprise, 7 out of the 8 mutants turned out to be flagellar mutants. Three 
mutants, OT3F12, OT5A2 and OT7C12 had disrupted putative flagellar basal body 
proteins flgA, flgB and flgG respectively (Figure 4.3.2 A). These mutants are likely to 
have no flagellar basal bodies assembled. Two mutants, OT3H1 and OT6H3, had 
transposon inserted after the promoter or near the end of the fliC gene (Figure 4.3.2 B), 
which encodes the flagellin protein, the building blocks of flagella. OT5D5 disrupted 
fliI gene (Figure 4.3.2 C), predicted to encode a flagellum-specific ATP synthase, 
required for flagellar secretion and assembly. The last flagellar mutant was OT10G11, 
which had a disrupted flhD gene (Figure 4.3.2 D), predicted to be a subunit of flagellar 
regulon master regulator. The only non-flagellar mutant was OT9H7, which had Tn5 
inserted in one of the bsa TTSS structure gene bsaU, which is in the same gene operon 
as bsaQ (Figure 4.3.2 E). It is unlikely that there was a second copy of transposon 
present in the mutant genome as the chance of transposon integration is very low 
(Merriman and Lamont, 1993). However, we will have to perform Southern blot on 
the mutant DNA to confirm this.  
 
Table 4.1 Summary of transposon mutants.  




Putative function Motility 









2 OT3H1 flagellin BPSL3319 non-motile
Tn5-3H1H 
Tn5-5A2E flgB 3 OT5A2 flagellar basal-body rod 
protein (BPSL0270) 
non-motile
Tn5-5D5E fliI 4 OT5D5 flagellum-specific ATP attenuated 
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Tn5-5D5N synthase (BPSL0227) motility 
Tn5-6H3E fliC 5 OT6H3 flagellin (BPSL3319) non-motile
Tn5-6H3N 
6 OT7C12 Tn5-7C12E flgG flagellar basal-body rod 
protein (BPSL0275) 
non-motile
Tn5-9H7E Bsa TTSS (BPSS1539), 
weak homology to InvJ, 
needle length control 
protein 






flhD (BPSL3311) flagellar 






It has been shown that flagellum is essential for motility in B. pseudomallei (Chua et 
al., 2003) and other bacteria. To find out whether flagellar mutants were truly 
defective in flagellum function, we tested the motility of mutants on soft agar. Wild 
type bacteria stab-inoculated on the center of 0.3 % TSB agar was able to spread over 
the entire plate overnight (Figure 4.3.3). In contrast, flgA, flgB, flgG, flhD and the two 
fliC mutants all showed no or very little motility on soft agar. Thus these genes are 
most likely encoding functional flagellar components (Table 4.2). Interestingly, in 
mutant OT6H3, the transposon is inserted at the near end of the fliC gene (Figure 4.3.2 
C). The mutated protein had only the last few amino acids of the C-terminal modified.  
This suggests that C-terminal of flegallin is critical for its function. fliI mutant 
(OT5D5) had some residual motility as it can spread over a bigger area on the agar as 
compared to other flagellar mutants. FliI protein is highly conserved among flagellated 
bacteria. FliI of B. pseudomallei shares 77 % sequence homology with that of 
Salmonella. It is a flagellum-specific ATP synthase (Vogler et al., 1991) and it is 
required for flagellar secretion and assembly (Suzuki et al., 1978). fliI mutant of 
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Salmonella has no flagellum and is non-motile (Suzuki et al., 1978). In mutant OT5D5, 
Tn5-OT182 was inserted very close to the end of the gene (Figure 4.3.2 C). It is very 
likely that the truncated protein still has residual ATPase function, which might have 
led to residual flagellar function.  
 
Table 4.2 Comparison of B. pseudomallei flagellar proteins to that of S. typhimurium 
LT2.  
Protein Homology to Salmonella 
protein (GI number) 
Phenotype of Salmonella mutant 
(Ref) 
Nonflagellated (Suzuki et al., 1978)  FlgA 50 %  (GI:16764529) 
Nonflagellated (Suzuki et al., 1978) FlgB 61 %  (GI:16419691) 
Nonflagellated (Suzuki et al., 1978) FlgG 84 % (GI:16419696) 
Nonflagellated (Suzuki et al., 1978) FliC 46 % (GI:16420494) 
Nonflagellated  ( Suzuki et al., 1978) FlhD 71 % (GI:16420463) 
Nonflagellated  ( Suzuki et al., 1978) FliI 77 % (GI:16420507) 
 
The only non-flagellar mutant identified is OT9H7, which has a Tn5-OT182 inserted 
in the bsaU gene within bsa TTSS (Figure 4.3.2 E). bsa TTSS genes share extensive 
homologies to those of SPI-I of Salmonella  (Stevens et al., 2002). Most of the 
proteins within the bsaO-Z operon encoding mostly secretion apparatus have 40 to 80 
% homology (Table 4.3). However, bsaU is the least conserved one. BsaU protein has 
only 26 % of homology with the InvJ, the counter part in SPI-I. InvJ is important in 
controlling the length of the needle substructure of TTS complex. invJ mutant of 
Salmonella has abnormally long needle substructure and it is defective in cell invasion 
(Sukhan et al., 2001). To find out whether BsaU is truly a functional homolog of InvJ, 
it is necessary to study the assembly of the needle substructure in OT9H7. 
Nevertheless, OT9H7 did have defective bsa-dependent secretion. We examined the 
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presence of BopE and BipD in the culture medium of OT9H7 by Western blot as 
described in chapter 2. As shown in Figure 2.5.1, BopE secreted by OT9H7 was only 
about 25 % of that by wild type. In comparison, there was no detectable BopE secreted 
by bsaQ. BipD was barely detectable in the supernatant of both bsaQ and bsaU. When 
we took a second look at the cytotoxicity data presented in Figure 4.2.2 and 4.2.3, 
OT9H7 consistently showed slightly higher cytotoxicity than bsaQ. Thus, it is very 
likely that the residual function of bsa TTSS contributed to the residual cytotoxicity. 
This is in accord with the theory that bsa TTSS is required for B. pseudomallei 
induced macrophage cytotoxicity.    
 
Table 4.3 Homology of bsa proteins to that of SPI-I of S. typhimurium LT2. 
Protein Homology to Salmonella 
protein (GI number) 
Function Phenotype of 
Salmonella 
mutant 
BsaO InvG 61 %   Needle complex No needle  
(GI: 16421446) Outer membrane 
BsaP InvE 48 %   Unknown No secretion 
(GI: 16766203) 
BsaQ InvA 74 %  Export apparatus  No needle 
(GI: 16421444) Inner membrane 
BsaR InvB 48 %  Chaperone for 
effectors 
No secretion of 
some effectors (GI: 16421443) 
BsaS InvC 73 %  Export apparatus No needle 
GI: 16421442) Inner membrane 
BsaT InvI/SpaM 45 %  Secretion protein No needle 
(GI: 16421441) Membrane associated 
BsaU InvJ/SpaN 26 %  Needle length control Long needle  
(GI: 16421440) No secretion 
BsaV SpaO 40 %   Export apparatus No needle 
(GI: 16421439) Inner membrane 
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BsaW SpaP 79 %  Export apparatus No needle 
(GI: 16421438) Inner membrane 
BsaX SpaQ 77 %  Export apparatus No needle 
(GI: 16421437) Inner membrane 
BsaY SpaR 63 %  Export apparatus No needle 
(GI: 16421436) Inner membrane 
BsaZ SpaS 64 %  Export apparatus No needle 
(GI: 16421435) Inner membrane 
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 Figure 4.3.2 Transposon insertion loci. Gene names were given according to annotated 
B. pseudomallei genome in Genbank.  
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4.3.4 Flagellin and cytotoxicity  
It seemed that motility is another independent factor required for B. pseudomallei 
induced macrophage oncosis other than bsa TTSS. The simplest explanation would be 
that non-motile bacteria are less efficient in cell invasion. These mutants probably had 
less chance to come in contact with macrophages, consequently with lesser chances of 
being phagocytosed and contributing to diminished cytotoxicity. This can be 
overcome by a brief centrifugation of cell culture plates after bacteria inoculation. 
After centrifugation, bacteria and cells would be brought to close contact at the bottom 
of the well. This would increase the chance of uptake and invasion. We infected THP-
1 cells and murine macrophages with motility mutants and compared the cytotoxicity 
between wells with or without centrifugation. As shown in figure 4.4.1A, after a brief 
centrifugation, motility mutants killed 15-25 % more THP-1 cells. Moreover, 
centrifugation restored the cytotoxicity of motility mutants to wild type level (Figure 
4.4.1B). In comparison, centrifugation had no or only marginal effect on cytotoxicity 
of bsa TTSS mutants bsaQ and OT9H7, because they were both as motile as wild type 
(Figure 4.3.3 and data not shown). We conclude that motility of B. pseudomallei is not 
likely to be directly involved in macrophage cytotoxicity.  
 
Several recent publications showed that flagellin from Gram-negative bacteria can 
activate caspase-1 through adaptor protein Ipaf (Miao et al., 2006; Franchi et al., 
2006). This pathway is independent of bacterial motility and flagellar secretion but 
rather dependent on TTSS. The expression of flagellin gene is highly regulated 
(Chilcott and Hughes, 2000). Deficiency in master regulator, basal body proteins, 
flagellar secretion components should all prevent the expression of flagellin. We thus 
examined the expression of flagellin in all our flagella mutants by Western blot using 
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anti-flagellin polyclonal serum generated previously in the lab (Koo G.C.). As 
expected, flagellin was not expressed in any non-motile mutants (Figure 4.4.2). 










 Figure 4.4.1 Centrifugation restored the cytotoxicity of motility mutants. After 
bacterial inoculation, cell culture plates were centrifuged for 10 minutes at 600 g (Spin, 
black bar) or placed in incubator straightway (No spin, open bar). (A). For mouse 
macrophages (B), centrifugation restored cytotoxicity for all flagellar mutants, but 
there was no effect on TTSS mutants, bsaQ and OT9H7 (bsaU::Tn5-OT182). For 
mouse macrophages, data presented were mean and standard deviation of results from 
two independent experiments using macrophages from at least 3 animals except for 
bsaQ, which was done only once with no detectable cytotoxicity. (**p<0.01, *p<0.05). 
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 Figure 4.4.2 Expression of flagellin in B. pseudomallei motility mutants. Flagellin can 
be detected in wild type bacteria but not in motility mutants by Western blot. Only 
trace amount of flagellin was detected in fliI mutant, which is not completely non-
motile. Arrow shows the position of flagellin and the star (*) indicates the non-specific 
















4.4.1 Screening method 
In this study, we developed a screening system based on macrophage killing assay to 
identify mutants with potentially attenuated in vivo virulence. To increase the 
efficiency of screening, we first visually screened mutants based on their ability to 
induce the characteristic oncotic swelling in THP-1 cells. Although this step allowed a 
large margin of error, it proved to be powerful in reducing the number of mutants we 
needed to handle subsequently. Visual screening sounds practically tedious to perform, 
but in our experience it took about 30 minutes to look through all the wells on one 
plate. Assuming two plates of mutants are screened each time and screening is done 
twice a week, one experienced person can screen 1000 mutants per month easily (2 x 2 
x 4 x 96=1536). We believe that this protocol can be employed to screening a 
saturated library of mutants efficiently for major bacterial factors involved in the 
induction of macrophage cell death pathway. There are possibly many genes involved 
in different steps in the cell invasion, phagosome survival and escape, and activation 
of caspase-1 and cell death.  By defining the role of each of the bacterial proteins 
identified by screening, we would be able to construct a detailed map of bacterial 
induced macrophage cell death. 
 
4.4.2 Role of bsa TTSS in macrophage cytotoxicity and caspase-1 activation 
We have shown in chapter 3 that bsa TTSS is involved in macrophage cytotoxicity 
and probably caspase-1 activation. In contrast to published data (Stevens et al., 2002), 
our preliminary data suggested that bsaQ is able to escape from the endocytic vesicles 
into the cytosol as efficiently as wild type bacteria (Hii et al., 2006, manuscript 
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submitted). Based on this new data, it is highly unlikely that the inability of the bsaQ 
mutant to kill macrophages is due to its inability to escape the endosome, as we had 
proposed as one possible explanation in chapter 3. Thus it is likely that some bsa-
dependent secreted effector(s) triggers the activation of caspase-1 and subsequent cell 
death. Consistent with this idea, we identified another bsa TTSS mutant through 
screening of transposon library. The mutant, OT9H7 (bsaU::Tn5-OT182) is defective 
in secretion of known effector BopE, and it has highly attenuated cytotoxicity to 
macrophages. We shall continue the screening to identify the specific effector(s) 
required for macrophage cytotoxicity.  
 
4.4.3 Flagellin induced caspase-1 dependent macrophage cell death 
It is well established that Shigella and Salmonella induce caspase-1 dependent 
macrophage cell death using TTSS-dependent factors (Chen et al., 1996; Hersh et al., 
1999). The key virulence factor was suggested to be IpaB/SipB, which was shown to 
be able to interact with caspase-1 and induce its activation. However, this model was 
challenged with recent publications. Two groups independently demonstrated that 
cytoplasmic flagellin activates caspase-1 via adaptor protein Ipaf in Salmonella-
infected macrophages (Miao et al., 2006; Franchi et al., 2006). The delivery of 
flagellin into cytosol is independent of flagellar secretion system, but it is dependent 
on SPI-1 TTSS. Most importantly, in the absence of flagellin, activation of caspase-1 
by Salmonella was greatly reduced. Thus it appears that the role of SipB, being part of 
the TTSS transmembrane pore complex, in caspase-1 activation is to facilitate the 
delivery of flagellin into the cytoplasm. B. pseudomallei has a TTSS system and a 
flagellar system with very high homology to those of Salmonella. We have shown in 
chapter 3 that bsa TTSS is required for caspase-1 dependent cell death. However, B. 
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pseudomallei flagellin is not likely to play an important role in caspase-1 activation in 
our system. Firstly, flagellin was not expressed in flhD, flgA, flgB flgG, fliC and fliC 
promoter mutants (Figure 4.4.2), but these mutants were fully cytotoxic to 
macrophages after centrifugation to overcome the motility defect (Figure 4.4.1). 
Secondly, macrophage oncosis induced by flagellin mutants was most likely still 
caspase-1 dependent, as they induces similar rate of cell lysis (Figure 4.4.1) with un-
differentiable oncotic phenotype as wild type bacteria (data not shown). Thirdly, B. 
mallei has a flagellin (GI:53724342) of exactly the same sequence as those of B. 
pseudomallei, yet it was not cytotoxic to THP-1 cell (Figure 3.4.1). Thus caspase-1 
activation by B. pseudomallei might not be through flagellin and Ipaf. To identify the 
pathway of caspase-1 activation by B. pseudomallei, we should test the sensitivity of 
Ipaf or other adaptor gene-deficient macrophages to B. pseudomallei infection. Ipaf 
belong to the CATERPILLER (CARD, transcription enhancer, R(purine)-binding, 
pyrin, lots of LRRs) protein family of proteins (Harton et al., 2002). Different 
pathogens and microbial products use a diverse range of adaptor protein to activate 
caspase-1 (Mariathasan et al., 2006). It will be interesting to find out which adaptor is 
required for activation by B. pseudomallei. For the bacterium, we need to continue to 










Chapter 5      Summary and future directions  
 
5.1 Mechanism of caspase-1 activation by B. pseudomallei  
In chapters 3 and 4, we have described an oncotic macrophage cell death triggered by 
virulent B. pseudomallei strains. During infection, caspase-1 is activated by bacterial 
products. Caspase-1 is the key protein controlling the maturation of two important 
inflammatory cytokines, IL-1β and IL-18. Recently, it was discovered that caspase-1 
was activated in a multi-member protein complex, the inflammasome, which has 
functional and structural resemblance to the apoptosome formed in the intrinsic 
apoptosis pathway (Petilli et al., 2005). Subsequently, several adapter proteins in the 
inflammasome were found and their roles in caspase-1 activation by different bacterial 
pathogens were established (Mariathasan et al., 2004; Martinon et al., 2004; 
Kanneganti et al., 2006). However, the exact bacterial product of each pathogen that 
triggers the formation of inflammasome is not yet defined in all cases.  
 
Caspase-1 activation and caspase-1 dependent macrophage cytotoxicity during 
Salmonella infection were recognized many years ago (Hersh et al., 1999). The 
activation was absolutely dependent on the SPI-I TTSS. It was long thought that SPI-I 
translocator and effector SipB was responsible for caspase-1 activation (Hersh et al., 
1999). However, several recent papers demonstrated that flagellin deficient 
Salmonella mutants are unable to activate caspase-1 despite the fact that SPI-I TTSS is 
fully functional in these strains (Miao et al., 2006; Franchi et al., 2006).  It was further 
demonstrated that direct delivery of flagellin activated caspase-1 (Franchi et al., 2006). 
Previously, it was also shown that recombinant SipB delivered into cytosol by 
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microinjection activated caspase-1 (Hersh et al., 1999). In retrospect, it was likely that 
the recombinant SipB was contaminated with flagellin during protein purification.  
 
Activation of caspase-1 by B. pseudomallei requires the bsa TTSS, which has high 
homology to SPI-I of Salmonella. To identify the bacterial protein that is required for 
caspase-1 activation, we screened a small pool of random transposon mutants of B. 
pseudomallei for those with attenuated macrophage cytotoxicity. Seven out of eight 
mutants identified were flagella mutants. However, a brief centrifugation restored 
cytotoxicity of all flagella mutants to mouse macrophages. Presumably, caspase-1 is 
activated by these mutants as the phenotype of macrophage cell death induced is 
undifferentiable from that of wild type bacteria. Western blot confirmed that flagellin 
was not expressed in all but one flagella mutants. Thus, we have discovered a TTSS-
dependent but flagellin-independent mechanism of oncotic macrophage death by B. 
pseudomallei. However, before we can reach a definitive conclusion, we need to rule 
out the possibility that flagella mutants induced a caspase-1-independent oncotic 
macrophage cell death. This can be done by Western blot probing for mature caspase-
1 fragments after infection of macrophages by flagella mutants to show that the death 
we are observing is still caspase-1 dependent.  
 
Flagellin activates caspase-1 through Ipaf (Miao et al., 2006). It will be interesting to 
find out which adaptor is required for caspase-1 activation by B. pseudomallei. 
Knockout mice of several adaptor proteins are available now. Cells from these mice 
can be infected with B. pseudomallei in vitro to find out which cells are still sensitive 
to caspase-1 dependent death. These mice together with caspase-1 KO mice can also 
be used for in vivo studies to define their roles in the pathogenesis of B. pseudomallei.  
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 Since B. pseudomallei flagellin is not the factor that activates caspase-1, we need to 
continue screening from the random transposon library. For future screening 
experiments, centrifugation will be performed after bacterial inoculation to avoid 
picking out motility mutants.  
 
One interesting feature of oncosis induced by B. pseudomallei is the involvement of 
pore formation. However, we do not know whether pore formation is upstream or 
downstream of caspase-1 activation. Defining the order of these two events will 
provide valuable insights into the mechanism of caspase-1 activation by B. 
pseudomallei and the mechanism of caspase-1 dependent macrophage cell death. We 
have shown that PEG4000 is able to inhibit the cell lysis induced by B. pseudomallei 
by plugging the pores. It will be of great interest to find out whether caspase-1 has 
been activated in the presence of PEG4000. If pore formation is required for caspase-1 
activation, we would expect to see that PEG4000 treatment delays or even prevens 
caspase-1 formation. One possible mechanism for pore formation to activate caspase-1 
is through leakage of intracellular K+ ions through the pores. It has been shown that 
depletion of intracellular K+ ions through ATP gated P2X7 channel or nigericin, a 
K+/H+ ionophore, activates caspase-1 (Kahlenberg and Dubyak, 2004). If this theory is 
correct, we would expect that high concentration of K+ in the cell culture medium 
should delay or even prevent bacterial induced caspase-1 activation. On the other hand, 
if pore formation is the consequence of caspase-1 activation, PEG4000 should not 




5.2. Role of macrophage cell death in pathogenesis 
Induction of macrophage cell death is a common feature of bacterial infection (Hilbi et 
al., 1997). For some bacteria like Mycobacterium, strains or mutants that are less 
virulent induce more macrophage cell death (Winau et al., 2004; Winau et al., 2005). 
In contrast, for bacteria like Salmonella, macrophage cytotoxicity mutants are less 
virulent in animals (Hueffer and Galan, 2004). It is unclear whether macrophage dies 
as a form of host defense or is a consequence of the virulence mechanism of the 
pathogen. The precise role of macrophage cell death during infection might depend on 
the form of cell death induced. We have observed that the caspase-1 dependent 
macrophage cell death is associated with virulence of B. pseudomallei strains. Virulent 
Shigella and Salmonella strains are also well known to induce caspase-1-dependent 
macrophage cell death. However, there are mounting evidences suggesting that 
caspase-1 is required for host defense against these bacteria. Caspase-1 KO mice are 
more susceptible to infection by Shigella flexneri (Sansonetti et al., 2000) and Listeria 
monocytogenes (Tsuji et al., 2004). So is macrophage cell death merely the by-product 
of an over-activated caspase-1? Or does the death have any significant implications 
unrelated to caspase-1? These questions cannot be answered by studies using caspase-
1 KO mice because of the confounding requirement of caspase-1 for host defense. 
However, knockout mice of adaptor proteins of caspase-1 activation can be used for 
this purpose. Activation of caspase-1-dependent macrophage cell death by Salmonella 
requires ASC and Ipaf but not NALP1/3 (Mariathasan et al., 2004; Mariathasan et al., 
2006). So macrophage cell death should not occur in ipaf KO mice after Salmonella 
infection, while caspase-1 mediated immunity could still be activated by bacterial LPS. 
In contrast, macrophage cell death should not be affected in Nalp1/3 KO mice. By 
comparing the two strains of mice, we should be able to learn more about the role of 
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macrophage cell death in disease. It was reported recently that neither ipaf nor Nalp3 
mice showed significant difference from wild type animals in terms of sensitivity to 
Salmonella infection (Lara-Tejero et al., 2006). Would it be the same for B. 
pseudomallei? It would be difficult to predict but interesting to know as it might 
contribute to the understanding of disease pathogenesis.  
 
5.3 Role of bsa TTSS in pathogenesis 
It has been shown that bsa TTSS mutants have greatly attenuated virulence in mice 
(Stevens et al., 2004) and hamsters (Warawa and Woods, 2005), but mutants of known 
TTSS effectors show little attenuation in virulence compared to wild type bacteria 
(Stevens et al., 2004). These results confirm the important role of bsa TTSS in 
pathogenesis. However, the immune response induced by bsa TTSS mutants is not yet 
characterized. We have shown in vitro that bsaQ mutant infected macrophages 
produce less inflammatory cytokines. As over production of inflammatory cytokines 
in acute disease might contribute to pathogenesis (Gan, 2005), it will be particularly 
meaningful to delineate the cytokine profile in bsaQ infected mice. Research in this 
direction might shed light on new treatment of acute melioidosis.  
 
5.4 Concluding remarks 
Melioidosis is still a potentially life threatening disease in endemic areas. With 
increased global traveling, it is possible for this disease to spread to other parts of the 
world. The treatment of this disease is difficult and the mortality rate of acute 
melioidosis is still as high as 40-50 % despite intensive antibiotic treatment. Research 
in recent years has uncovered many putative virulence factors. However, it is 
challenging to define the roles of these factors in vivo in disease pathogenesis. 
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Hopefully with the identification of the bacterial product(s) and host cellular factors 
involved in the caspase-1 induced macrophage cell death, we would be able to define 
both the role of caspase-1 and macrophage cell death in pathogenesis of B. 
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1. 4th Combined Annual Scientific Meetings, May 2003, Singapore 
 
INDUCTION OF MACROPHAGE CELL DEATH BY BURKHOLDERIA 
PSEUDOMALLEI 
Guang-Wen Sun and Yunn-Hwen Gan 
Department of Biochemistry, National University of Singapore 
 
Abstract 
Burkholderia pseudomallei is the causative agent for melioidosis, an emerging 
infectious disease in tropical and subtropical regions with a wide spectrum of clinical 
outcomes. The bacterium is a facultative intracellular microbe with broad tissue 
tropism.  However, the pathogenesis of the disease is poorly understood. We have 
observed that a virulent clinical isolate of B. pseudomallei, strain KHW, induces cell-
death in a mouse macrophage cell line. Extensive cell lysis begins at four hours after 
infection and more than 80% of cells are lysed by eight hours.  The lysis of J774 cells 
by KHW is caspase-independent, and DNA ladder is not observed in infected cells. 
Bacterial  entry into cells is important for cell lysis as the inhibition of phagocytosis 
reduces bacterial invasion, and thus cell death. Prolonged-exposure to bacteria is not 
required to induce cell death. This relatively rapid cell lysis induced by the bacterium 
is unique to macrophages and dendritic cells as KHW induces apoptotic death in 
epithelial cells one day after infection. Therefore, it is important to determine the 
mode of cell death induced by the bacterium, and the bacterial factors responsible for 
this induction. Furthermore, since the lysis is host cell-type specific, it is likely that 










2. 4th World Melioidosis Congress, 16 Sept, 2004, Singapore 
 
VIRULENT BURKHOLDERIA PSEUDOMALLEI STRAINS INDUCE 
CASPASE-1 CELL DEATH IN MACROPHAGES 
Guang Wen Sun1, Jinhua Lu2, Wei Peng Cao2 and Yunn-Hwen Gan1* 
1Department of Biochemistry and 2Department of Microbiology  
National University of Singapore 
 
ABSTRACT: Burkholderia pseudomallei is the causative agent for melioidosis, an 
infectious disease endemic in South-east Asia and northern Australia. Infection can 
result in a wide spectrum of clinical outcomes, including asymtomatic, acute or 
chronic conditions. The ability of the bacterium to survive intracellularly within 
phagocytes and non-phagocytes is postulated to help the bacterium persist in the body 
during latent chronic conditions. In many Gram-negative bacteria, the ability to evade 
macrophage killing involves inducing rapid macrophage cell death. In several of these 
instances, the bacterium employ a mechanism involving Type III secretion systems 
(TTSS) to induce death which is increasingly described to exhibit features more 
characteristic of oncosis than classical apoptosis. In fact, we found that virulent strains 
of B. pseudomallei are also capable of inducing oncotic death in macrophages and 
dendritic cells and this process is dependent on the bsa TTSS locus. Bacterial 
internalisation and pore formation in the cell membrane is necessary for death. We 
believe that this novel description of macrophage death induced by B. pseudomallei 









3. Keystone Symposium, Jan 2005, USA 
VIRULENT BURKHOLDERIA PSEUDOMALLEI STRAINS INDUCE 
CASPASE-1-DEPENDENT CELL DEATH IN MACROPHAGES 
 
Guang Wen Sun1, Jinhua Lu2, Wei Peng Cao2 and Yunn-Hwen Gan1* 
1Department of Biochemistry and 2Department of Microbiology  
National University of Singapore 
 
ABSTRACT: Burkholderia pseudomallei is the causative agent for melioidosis, an 
infectious disease endemic in South-east Asia and northern Australia. Infection can 
result in a wide spectrum of clinical outcomes, including asymtomatic, acute or 
chronic conditions. The ability of the bacterium to survive intracellularly within 
phagocytes and non-phagocytes is postulated to help the bacterium persist in the body 
during latent chronic conditions. In many Gram-negative bacteria, the ability to evade 
macrophage killing involves inducing rapid macrophage cell death. In several of these 
instances, bacteria employ a mechanism involving Type III secretion systems (TTSS) 
to induce death which is increasingly described to exhibit features more characteristic 
of oncosis than classical apoptosis. In fact, we found that virulent strains of B. 
pseudomallei are also capable of inducing oncotic death in macrophages and dendritic 
cells and this process is dependent on the bsa TTSS locus. Bacterial internalisation 
and pore formation in the cell membrane is necessary for death. We believe that this 
novel description of macrophage death induced by B. pseudomallei sheds light on the 

















1. Media and supplements 
1.1  Luria-Bertani (LB) agar or LB broth   
bacto-tryptone (Becton Dickinson)             1 % (w/v)           
yeast extract (Becton Dickinson)                1 % (w/v) 
NaCl (Merck)  0.5 % (w/v) 
pH 7 with 1 M NaOH 
1.5 % (w/v) technical agar – for LB agar (Becton Dickinson) 
Autoclaved at 121oC, 15 PSI for 15 minutes 
 
1.2  Complete RPMI or antibiotic free RPMI 
RPMI (Sigma)  
Fetal calf serum (FCS)                               10 %  
L-glutamine                                                 200 mM 
penicillin     100 Unit/mL  
streptomycin   100 μg/mL 
 
2. Buffers 
2.1 DNA gel electrophoresis buffers 
2.1.1 0.5M EDTA, pH 8 
EDTA.2H 0 186.1 g Na2 2
Deionized H 0  800 ml 2
pH adjusted to 8 using about 20g of NaOH pellets (EDTA will 
not dissolve until pH was adjusted to about 8) 
Autoclaved at 121oC, 15 PSI for 15 minutes 
 
2.1.2 10X TAE (Tris-acetate-EDTA) buffer 
Tris base (Sigma)  48.4 g 
Glacial acetic acid (Sigma) 11.4 ml  
0.5 M EDTA (pH 8)  10 ml 
Deionized water   800 ml  
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pH adjusted to 8.5 before the volume was topped up to 1l with 
deionized water. Working strength for running buffer and gel 
preparation is 1X 
 
2.1.3 5X TBE buffer (Tris-borate-EDTA) buffer 
Tris base (Sigma) 54 g 
Boric acid (Sigma) 27.5 g   
0.5 M EDTA (pH 8) 20 ml  
Deionized water added to 1l. The pH should be at 8.3 and 
required no adjustment.Working strength for running buffer and 
gel preparation is 0.5X 
 
2.1.4 6X loading dye 
Bromophenol blue (Sigma)  0.252 g 
Deionized water   60 ml 
Mixed until bromophenol blue was completely dissolved before 
10 ml of glycerol (Sigma) was added. Mixture topped up with 
deionized water to 100 ml after glycerol was thoroughly mixed 
in solution. 
 
2.1.5 1 % (w/v) agarose gel 
Agarose (Gibco BRL)   0.5 g 
10X TAE or 5X TBE buffer  50 ml 
Mixture heated in microwave oven at medium heat for 3 minutes 
to totally dissolve agarose, allowed cooling to 50oC before 1 μl of 
5mg/ml ethidium bromide was added and poured into gel tray for 
gel to set.  
  
 
2.2 Southern blot buffers 
2.2.1 Depurination solution 
Concentrated HCl 20.8 mL 
Deionized water 1 L 
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 2.2.2 Denaturation solution 
NaOH   20 g 
NaCl  58.4 g 
Deionized water  1 L 
 
2.2.3 Neutralization solution 
Tris base 78.8 g 
NaCl 87.6 g 
Deionized water 800 mL 
Adjust pH to 7.4, add water to 1 L  
 
2.2.4 20x SSC 
NaCl   175.3g 
Citric acid  88.2 g 
Deionized water  1L 
 
2.2.5 Hybridization Solution 
20X SSC 10 mL 
10% (w/v) N-lauroylsarcosine     400 μL   
20% (w/v) SDS                      40 μL  
Stock blocking reagent            8 mL  
Deionized water                      21.56 mL 
 
2.2.6 Maleic acid buffer 
Maleic Acid 0.1 M 
NaCl 0.15 M 
adjusted pH to 7.5 with concentrated or solid NaOH: 
autoclaved. 
 
2.2.6 Blocking buffer 
stock blocking reagent 100 mL  
Maleic acid Buffer 900 mL  
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 2.2.7 Detection buffer 
Tris base 100 mM, pH 9.5 
NaC l 100 mM 
MgCl 50 mM 2
Prepare detection buffer from sterile stock solutions to 
avoid precipitation of MgCl2. Adjust the pH to 9.5 prior 
to addition of the MgCl2 or it will precipitate. 
 
2.2.7 CSPD solution 
20 μL of stock CSPD to 2 mL of detection buffer 
 
2.3 Western blot buffers 
2.3.1 1.5 M-Tris-HCl buffer, pH 8.8 
Trizma base (Sigma) 18.2 g 
Deionised water  80 ml 
The pH was adjusted to 8.8 with concentrated HCl and made up to 
100 ml with deionised water and stored at 4oC. 
2.3.2 0.5 M-Tris-HCl buffer, pH 6.8 
Trizma base (Sigma) 6 g 
Deionised water  80 ml 
The pH was adjusted to 6.8 with concentrated HCl and made up to 
100 ml with deionised water and stored at 4oC. 
 
2.3.3 10% (w/v) SDS solution 
Sodium dodecyl sulphate 10 g 
Deionized water   100 ml 
Stored at room temperature. 
2.3.4 10% (w/v) ammonium persulphate solution  
Ammonium persulphate 0.1 g 
Deionized water   1 ml 
The solution was always prepared freshly prepared prior to use. 
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2.3.5 Running buffer 
Trizma base  6.0 g 
Glycine  28.8 g 
10 % SDS (w/v)  10 ml  
Deionized water  1l 
Stored at 4oC. 
 
2.3.5 6X sample loading buffer 
0.5 M-Tris-HCl buffer, pH 6.8  2.5 ml 
glycerol    2.0 ml 
SDS 10% solution (w/v)  4.0 ml 
DTT      0.31 g 
bromophenol blue    0.1 mg 
Made up to 10 ml with water. The buffer was stored as 1 ml 
aliquots at -20oC.  
 
2.3.6 Gel preparation (for 2 Mini-Protean gels) 
Composition of the separating and stacking gels in SDS-PAGE. 
Reagents Separating gel (15% T*)  Stacking gel (6% T) 
Acrylamide solution 6 ml 1 ml 
1.5 M-Tris-HCl buffer, pH 8.8 5 ml - 
0.5 M-Tris-HCl buffer, pH 6.8 - 2.5 ml 
SDS solution 200 μl 100 μl 
Water 8.7 ml  6 ml 
Ammonium persulphate 100 μl 50 μl 
TEMED** 10 μl 5 μl 
*  % T refers to the total acrylamide content. 
** TEMED was added immediately before the casting of the slab gel. 
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